炎症反应与急性脑梗塞血瘀证的相关性研究
|
摘要
研究目的：血瘀证集中表现在一些血栓相关性疾病中，包括心脑血管疾病、外周动脉闭塞症、深静脉血栓等。在急性脑血管疾病中，炎症反应细胞因子相互调控，参与了脑血管病急症期的血液循环、血管的病理变化过程。我们假定炎症反应还参与了血瘀证的形成。调查急性脑梗塞患者和无脑梗塞对照组人口学因素、外周血的血液理化、血液生化、凝血相关指标、炎症反应因子与急性脑梗塞和急性脑梗塞血瘀证的相关性，从而探讨血瘀证形成的生物学基础。
研究方法：研究采用随机对照观察的方法，以急性脑梗塞患者为研究对象，并设立无脑梗塞对照组。收集全部病例的临床一般资料、血液理化、生化、凝血指标等资料；对全部病例进行中医临床辨证分析；每例病例抽取空腹静脉血3ml，用促凝管收集、立即离心超净工作台分离血清，-70℃保存，统一检测，所有过程均严格执行无菌操作，患者采血前均无感染及应用免疫佐剂或免疫抑制剂，采用酶联免疫吸附(ELISA)双夹心抗体法检测血清IL-1β、IL-6、TNF-α、TGF-β、sICAM-1、sVCAM-1含量，试剂盒购自北京环亚泰克生物医学技术有限公司，实验过程在北京中医药大学东直门医院药理实验室完成测定，所有操作均按说明书要求进行。将所收集的资料集中收集录入数据库，通过SPSS10.0统计软件进行统计分析。
结果：年龄为人口学因素资料，将病例按年龄＜70岁、年龄≥70岁分为两组，这时，年龄＜70岁组血瘀证35例，非血瘀证组32例；年龄≥70岁组血瘀证44例，非血瘀证19例，经Pearson卡方检验，P＜0.05，两者比较有显著差异。血瘀证分值与年龄相关分析，Pearson相关性系数为0.185，P＜0.05，血瘀证的分值随年龄的增加而增加。凝血酶原时间为血管性危险因素，血瘀证组与非血瘀证组之间凝血酶原时间分别为血瘀证组：12.16±0.95(秒)，非血瘀证组：12.52±1.03(秒)，t检验结果为：P＜0.05，血瘀证组凝血酶原时间缩短。通过对炎症反应因子含量进行分析：在血瘀证组内血瘀证分值与IL-1β水平的Pearson相关系数为0.354，P＜0.01，Spearman等级相关系数为0.305，P＜0.05，血瘀分值与IL-1β水平呈正相关。TNF-α水平与血瘀证的Pearson相关系数为-0.253，P＜0.05，Spearman等级相关相关系数为-0.264，P＜0.01，TNF-α水平与急性脑梗塞血瘀证Spearman等级相关系数为-0.254，P＜0.05，TNF-α水平与血瘀分值呈负相关。TGF-β1水平与急性脑梗塞血瘀证Pearson相关系数为-0.235，P＜0.05，TGF-β1水平与血瘀分值呈负相关。sICAM-1水平与急性脑梗塞血瘀证Spearman等级相关系数为0.342，P＜0.05，急性脑梗塞血瘀证与sICAM-1水平呈正相关。
结论：通过对急性脑梗塞组与对照组血瘀证、非血瘀证病例所收集的人口学资料、血管性危险因素如血液理化资料、血脂水平、血液凝集相关指标的相互比较，发现血瘀证相关的因素有年龄；可能与血瘀证相关的因素为凝血酶原时间；而以往所关注的血瘀证相关的因素诸如白细胞计数、血清D-二聚体含量是急性脑梗塞的相关因素。炎症反应因子IL-1β、IL-6、TNF-α、sICAM-1、sVCAM-1参与了急性脑梗塞的炎症反应过程，这些因子的异常升高与急性脑梗塞相关，TGF-β1升高与急性脑梗塞有相关趋势。IL-1β水平与血瘀证呈正相关；sICAM-1水平与急性脑梗塞血瘀证呈正相关；TNF-α水平与血瘀证呈负相关；TGF-β1水平与急性脑梗塞血瘀证呈负相关。炎症反应因子IL-1β、TNF-α、TGB-β1、sICAM-1可能为急性脑梗塞血瘀证的生物学基础，作为一种重要的中医病理过程-血瘀证，除与炎症反应因子IL-1β、TNF-α、TGB-β1、sICAM-1相关外，还有诸如年龄、凝血酶原时间等其他相关因素，血瘀证有可能是通过复杂的机制而完成其发生、发展、形成的过程，在探讨其发生发展形成时应尽可能的将所有影响因素都纳入研究内容，才有可能阐述其形成机制(本课题由国家重点基础研究发展计划973项目(2003CB517104)资助)。
BACKGROUND: Blood stasis syndrome usually occurs in diseases related to thrombussuch as cerebrovascular disease, cardiovascular disease, peripheryphlebothrombosis or arterial occlusions. Inflammatory reaction participate theacute cerebrovascular diseases course. These inflammatory cell factorparticipate the procedure of the acute cerebrovascular diseases. So we presumethat inflammatory reaction may be correlated to the emergence of blood stasissyndrome.
OBJECTIVE: Analyzing the age, blood pressure, blood examination, blood fat,inflammatory reaction cell factors between the cerebral infarction group andthe control group. Survey the relationship between these targets and the cerebralinfarction. To analyze blood stasis syndrome in both the cerebral infarctiongroup and the control group that without cerebral infarction was conducted toexplore the correlation between inflammatory factor and blood stasis syndrome.
METHODS: This subject is an observatory and controlled study based on patientswith cerebral infarction and without cerebral infarction. All these participantswere hospitalized at the Dongzhimen hospital which was the first affiliatedhospital of Beijing University of Traditional Chinese Medicine. We collectedthe name, age, sex, and other information from each participant, including bloodexamination, blood fat and index of blood coagulation and so on. We usequestionnaire to evaluate each participant's pattern identification. We alsodraw vein blood 3ml from each participant at the state of empty stomach for makingsera. All sera were hold in the-70 centi-degree refrigerator and were detectedtogether in pharmacological laboratory in Dongzhimen hospital. IL-1β、IL-6、TNF-α、TGF-β、sICAM-1 and sVCAM-1 were detected with the enzyme linkedimmunosorbent assay(ELISA) kit of IL-1、IL-6、TNF-α、TGF-β、sICAM-1 and sVCAM-1by the method of ELISA. At last, we finished our database and statisticalanalysis.
RESULTS: Age, as an demography information, is very important in this subject.We divided all participants into two groups. 70 years old is selected to be thedemarcation. In the group that with the participants in age＜70 years old, thereare 35 patients with blood stasis syndrome and 32 patients without blood stasissyndrome. In the group that with the participants in age≥70 years old, thereare 44 patients with blood stasis syndrome and 19 patients without blood stasissyndrome. Through Pearson chi-square criterion, we get the result P＜0.05. Thecorrelation test shows that Pearson coefficient correlation between age andblood stasis syndrome score is 0.185, P＜0.05, accompany with the increase ofage, the blood stasis syndrome score is increased. PT is an blood vessel Riskfactor. The PT level in patients with blood stasis syndrome is 12.16±0.95(s).The PT level in patients without blood stasis syndrome is 12.52±1.03(s). t test result shows P＜0.05. Patients with blood stasis syndrome have high PT levelcompare with the patients without blood stasis syndrome. Analyzing theinflammatory factor, the Pearson coefficient correlation between IL-1βleveland the blood stasis syndrome score is 0.354, P＜0.01. Spearman coefficientcorrelation is 0.305, P＜0.05. The result shows the positive correlation betweenIL-1βand blood stasis syndrome. The Pearson coefficient correlation betweenTNF-αlevel and the blood stasis syndrome score is -0.253, P＜0.05. Spearmancoefficient correlation is -0.264, P＜0.01. As the same, The Pearson coefficientcorrelation between TGF-β1 level and the blood stasis syndrome score is -0.235,P＜0.05. The result shows inverse correlation between TNF-αlevel/TGF-β1 leveland the blood stasis syndrome score. The Spearman coefficient correlationbetween sICAM-1 level and the blood stasis syndrome score is 0.342, P＜0.05. Thereis a relationship of positive correlation between sICAM-1 and blood stasissyndrome in cerebral infarction too.
CONCLUSION: The correlation factor of blood stasis syndrome is age. The possiblecorrelation factors of blood stasis syndrome are prothrombin time. Inflammatoryfactors IL-1β、IL-6、TNF-α、TGF-β、sICAM-1、sVCAM-1 are participate the cerebralinfarction course. The result shows the positive correlation between IL-1βandblood stasis syndrome. It shows inverse correlation between TNF-αlevel/TGF-β1 level and the blood stasis syndrome score too. Also there is a relationshipof positive correlation between sICAM-1 and blood stasis syndrome in cerebralinfarction. Inflammatory factor participate the cerebral infarction course. Andshow the different correlation with the blood stasis syndrome. Inflammatoryfactors as a biological factor maybe take part in the forming course of bloodstasis syndrome in patients with cerebral infarction. Blood stasis syndrome asan important pattern, may have more complicated mechanism in the course of happen,develop and form. (The project was supported by National 973 programe)
研究方法：研究采用随机对照观察的方法，以急性脑梗塞患者为研究对象，并设立无脑梗塞对照组。收集全部病例的临床一般资料、血液理化、生化、凝血指标等资料；对全部病例进行中医临床辨证分析；每例病例抽取空腹静脉血3ml，用促凝管收集、立即离心超净工作台分离血清，-70℃保存，统一检测，所有过程均严格执行无菌操作，患者采血前均无感染及应用免疫佐剂或免疫抑制剂，采用酶联免疫吸附(ELISA)双夹心抗体法检测血清IL-1β、IL-6、TNF-α、TGF-β、sICAM-1、sVCAM-1含量，试剂盒购自北京环亚泰克生物医学技术有限公司，实验过程在北京中医药大学东直门医院药理实验室完成测定，所有操作均按说明书要求进行。将所收集的资料集中收集录入数据库，通过SPSS10.0统计软件进行统计分析。
结果：年龄为人口学因素资料，将病例按年龄＜70岁、年龄≥70岁分为两组，这时，年龄＜70岁组血瘀证35例，非血瘀证组32例；年龄≥70岁组血瘀证44例，非血瘀证19例，经Pearson卡方检验，P＜0.05，两者比较有显著差异。血瘀证分值与年龄相关分析，Pearson相关性系数为0.185，P＜0.05，血瘀证的分值随年龄的增加而增加。凝血酶原时间为血管性危险因素，血瘀证组与非血瘀证组之间凝血酶原时间分别为血瘀证组：12.16±0.95(秒)，非血瘀证组：12.52±1.03(秒)，t检验结果为：P＜0.05，血瘀证组凝血酶原时间缩短。通过对炎症反应因子含量进行分析：在血瘀证组内血瘀证分值与IL-1β水平的Pearson相关系数为0.354，P＜0.01，Spearman等级相关系数为0.305，P＜0.05，血瘀分值与IL-1β水平呈正相关。TNF-α水平与血瘀证的Pearson相关系数为-0.253，P＜0.05，Spearman等级相关相关系数为-0.264，P＜0.01，TNF-α水平与急性脑梗塞血瘀证Spearman等级相关系数为-0.254，P＜0.05，TNF-α水平与血瘀分值呈负相关。TGF-β1水平与急性脑梗塞血瘀证Pearson相关系数为-0.235，P＜0.05，TGF-β1水平与血瘀分值呈负相关。sICAM-1水平与急性脑梗塞血瘀证Spearman等级相关系数为0.342，P＜0.05，急性脑梗塞血瘀证与sICAM-1水平呈正相关。
结论：通过对急性脑梗塞组与对照组血瘀证、非血瘀证病例所收集的人口学资料、血管性危险因素如血液理化资料、血脂水平、血液凝集相关指标的相互比较，发现血瘀证相关的因素有年龄；可能与血瘀证相关的因素为凝血酶原时间；而以往所关注的血瘀证相关的因素诸如白细胞计数、血清D-二聚体含量是急性脑梗塞的相关因素。炎症反应因子IL-1β、IL-6、TNF-α、sICAM-1、sVCAM-1参与了急性脑梗塞的炎症反应过程，这些因子的异常升高与急性脑梗塞相关，TGF-β1升高与急性脑梗塞有相关趋势。IL-1β水平与血瘀证呈正相关；sICAM-1水平与急性脑梗塞血瘀证呈正相关；TNF-α水平与血瘀证呈负相关；TGF-β1水平与急性脑梗塞血瘀证呈负相关。炎症反应因子IL-1β、TNF-α、TGB-β1、sICAM-1可能为急性脑梗塞血瘀证的生物学基础，作为一种重要的中医病理过程-血瘀证，除与炎症反应因子IL-1β、TNF-α、TGB-β1、sICAM-1相关外，还有诸如年龄、凝血酶原时间等其他相关因素，血瘀证有可能是通过复杂的机制而完成其发生、发展、形成的过程，在探讨其发生发展形成时应尽可能的将所有影响因素都纳入研究内容，才有可能阐述其形成机制(本课题由国家重点基础研究发展计划973项目(2003CB517104)资助)。
BACKGROUND: Blood stasis syndrome usually occurs in diseases related to thrombussuch as cerebrovascular disease, cardiovascular disease, peripheryphlebothrombosis or arterial occlusions. Inflammatory reaction participate theacute cerebrovascular diseases course. These inflammatory cell factorparticipate the procedure of the acute cerebrovascular diseases. So we presumethat inflammatory reaction may be correlated to the emergence of blood stasissyndrome.
OBJECTIVE: Analyzing the age, blood pressure, blood examination, blood fat,inflammatory reaction cell factors between the cerebral infarction group andthe control group. Survey the relationship between these targets and the cerebralinfarction. To analyze blood stasis syndrome in both the cerebral infarctiongroup and the control group that without cerebral infarction was conducted toexplore the correlation between inflammatory factor and blood stasis syndrome.
METHODS: This subject is an observatory and controlled study based on patientswith cerebral infarction and without cerebral infarction. All these participantswere hospitalized at the Dongzhimen hospital which was the first affiliatedhospital of Beijing University of Traditional Chinese Medicine. We collectedthe name, age, sex, and other information from each participant, including bloodexamination, blood fat and index of blood coagulation and so on. We usequestionnaire to evaluate each participant's pattern identification. We alsodraw vein blood 3ml from each participant at the state of empty stomach for makingsera. All sera were hold in the-70 centi-degree refrigerator and were detectedtogether in pharmacological laboratory in Dongzhimen hospital. IL-1β、IL-6、TNF-α、TGF-β、sICAM-1 and sVCAM-1 were detected with the enzyme linkedimmunosorbent assay(ELISA) kit of IL-1、IL-6、TNF-α、TGF-β、sICAM-1 and sVCAM-1by the method of ELISA. At last, we finished our database and statisticalanalysis.
RESULTS: Age, as an demography information, is very important in this subject.We divided all participants into two groups. 70 years old is selected to be thedemarcation. In the group that with the participants in age＜70 years old, thereare 35 patients with blood stasis syndrome and 32 patients without blood stasissyndrome. In the group that with the participants in age≥70 years old, thereare 44 patients with blood stasis syndrome and 19 patients without blood stasissyndrome. Through Pearson chi-square criterion, we get the result P＜0.05. Thecorrelation test shows that Pearson coefficient correlation between age andblood stasis syndrome score is 0.185, P＜0.05, accompany with the increase ofage, the blood stasis syndrome score is increased. PT is an blood vessel Riskfactor. The PT level in patients with blood stasis syndrome is 12.16±0.95(s).The PT level in patients without blood stasis syndrome is 12.52±1.03(s). t test result shows P＜0.05. Patients with blood stasis syndrome have high PT levelcompare with the patients without blood stasis syndrome. Analyzing theinflammatory factor, the Pearson coefficient correlation between IL-1βleveland the blood stasis syndrome score is 0.354, P＜0.01. Spearman coefficientcorrelation is 0.305, P＜0.05. The result shows the positive correlation betweenIL-1βand blood stasis syndrome. The Pearson coefficient correlation betweenTNF-αlevel and the blood stasis syndrome score is -0.253, P＜0.05. Spearmancoefficient correlation is -0.264, P＜0.01. As the same, The Pearson coefficientcorrelation between TGF-β1 level and the blood stasis syndrome score is -0.235,P＜0.05. The result shows inverse correlation between TNF-αlevel/TGF-β1 leveland the blood stasis syndrome score. The Spearman coefficient correlationbetween sICAM-1 level and the blood stasis syndrome score is 0.342, P＜0.05. Thereis a relationship of positive correlation between sICAM-1 and blood stasissyndrome in cerebral infarction too.
CONCLUSION: The correlation factor of blood stasis syndrome is age. The possiblecorrelation factors of blood stasis syndrome are prothrombin time. Inflammatoryfactors IL-1β、IL-6、TNF-α、TGF-β、sICAM-1、sVCAM-1 are participate the cerebralinfarction course. The result shows the positive correlation between IL-1βandblood stasis syndrome. It shows inverse correlation between TNF-αlevel/TGF-β1 level and the blood stasis syndrome score too. Also there is a relationshipof positive correlation between sICAM-1 and blood stasis syndrome in cerebralinfarction. Inflammatory factor participate the cerebral infarction course. Andshow the different correlation with the blood stasis syndrome. Inflammatoryfactors as a biological factor maybe take part in the forming course of bloodstasis syndrome in patients with cerebral infarction. Blood stasis syndrome asan important pattern, may have more complicated mechanism in the course of happen,develop and form. (The project was supported by National 973 programe)
引文
1．林求诚．面向21世纪的中国传统医学——证的研究现状和展望．中国中西医结合杂志，1997，17(7)；387-389．
2．王阶，陈可冀，翁维良，钱振淮，王怡，刘剑刚，葛争艳．血瘀证诊断标准的研究．中西医结合杂志，1988，8(10)；585-589．
3．王兆钱．血栓相关性疾病的临床流行病学．中华医学杂志，2004，84(5)；432-434．
4．吴承玉．血瘀证的研究发展脉络与评述．南京中医药大学学报，2004，20(3)；133-136．
5．高启龙，闫晓天．糖尿病肾病从瘀论治临床研究进展．河南中医学院学报，2004，19(111)；84-86．
6．谌剑飞．糖尿病缺血性中风中医证型与血清炎症细胞因子关系的研究．中国中西医结合急救杂志，2000，7(3)；147-149．
7．陈云波，王奇，赖世隆．从血管内皮细胞功能改变看血瘀证实质及活血化瘀机理[J]．中国中医基础医学杂志，1996，2(1)；37-38．
8．雷燕，黄启福，王永炎．论瘀毒阻络是络病形成的病理基础[J]．北京中医药大学学报，1999，22(2)；8-9．
9．郑萍．血栓闭塞性脉管炎患者血瘀证的血液学指标探讨[J]．中西医结合杂志，1986，6(6)；332-333．
10. Saito K, Suyam a K, Nishida K, et al. Early increases in TNF-α, IL6 and IL1 β levels following transient cerebral ischemia in gerbil brain. NeurosciLett, 1996, 206(2): 149-150.
11. Mathiesen T, Andersson B, Loftenius A, et al. Inereased interleakin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg, 1993, 78(4): 562.
12. SchettniG, Grimalai M, Landilfie, et al. Role of interleakin-6 in the neuroendocrine system. Acta Neurol, 1991, 24(13): 316.
13. Touzani O, Boutin H, Chuquet J, et al. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol, 1999, 100: 203-215.
14. Zheng GZ, Michael C, Anton G. Cerebral vessels express interleukin-1β after focal cerebral ischemia[J].Brain Research, 1998, 784: 210-217.
15. Nikolaos K, Pia K, Yumin H, et al. Ische mia stroke is associated with a systemic increase of blood mononuclear cells expressing interleukirr8 mRNA[J]. Stroke, 1998, 29; 462-466.
16. Zhai QH, Futrell N, Hen FJ.Gene expression of IL-10 in relationship to TNF-alpha, IL-1 beta and IL-2 in the rat brain following middle cerebral artery occlusion[J].Neurol Sci, 1997, 152: 119-124.
17. Buttini M, Appel K, Sauter A, et al.Expression of tumor necrosis factor alpha after focal cerebral ischemia in the rat[J]. Neuroscience, 1996, 71; 1-16.
18．毕国荣，卢丽萍，剑非．动态观察急性脑血管病患者血浆肿瘤坏死因子-α含量变化的临床意义．临床神经病学杂志，1999，12(2)；86-87．
19．黄作毅，韩凤，吴军．急性脑血管病患者血浆TNF、IL-6含量研究中风与神经疾病杂志，1999，16(2)：103-104．
20. Lehxm ann E, et al. Microglia and macrophages are major sources of locally proced transforming growth factor-betal after transient middle cerebral artery occlusion in rats. Glia, 1998, 24(4); 437-438.
21. Krupinski J, Kumar P, Kumar S, et al. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans[J]. Stroke, 1996, 27(5); 852-857.
22. Intiso D, Zarrelli MM, Lagioia G, Di Rienzo F, Checchia De Ambrosio C, Simone P, Tonali P, Cioffi Dagger RP. Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol Sci, 2004, 24(6); 390-396.
23. Robert MF, Valeria G, Hideaki H, et al.Expression of a dominant negative of interleukirrlp converting enzyme in transgenic mice prevents neuronal cell death induced by tropic fator withdrawal and ischemic brain injury[J]. EXP Med, 1997, 185; 933-940.
24. Frank CB, Raymond F W, Patricia AS, et al. Ischemic preconditioning and brain tolerance[J].Stroke, 1998, 29; 1937-1951.
25. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/ macro-phages in the pathogenesis of cerebral ischemia and stroke. Stroke, 1992,23; 1367.
26．杨金升．肿瘤坏死因子在脑卒中时的表达及应用．国外医学脑血管疾病分册，1996，4(2)；77-80．
27. Thomas JD. The role of inflammation after acute stroke[J].Neurolgy, 1998, 51; s62-s68.
28. Loddick SA, Turnbull AV, Rothwell NJ.Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat[J].Cerebral Blood Flow Metab, 1998, 18; 176-179.
29. Mallat Z, Gojova A, Marahiol-Fournigault C, et al. Inhibition of transforming growth factor-beta signaling accelerates atherosalerosis and induces an unstable plaque phenotype in mice[J]. Circ Res, 2001, 89(10); 930-934.
30. Argmann (:A, Van Den Diepstraten CH, Sawyez CG, et al. Transforming growth factor-β1 inhibits macrophage aholesteryl ester accumulation induced by native and ox-idized VLDL remnants[J]. Arterioscler Throm Vasc Biol, 2001, 21(12); 2011-2018.
31. Zuckerman SH, Panousis C, Evans G. TOF-beta reduced binding of high-density lipoproteins in murine macrophages and macrophage derived foam cells[J]. Atherosclerosis, 2001, 155(1); 79-85.
32. Minami M, Knme N, Kataoka H, et al. Transforming growth factor-beta(1) increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 [J]. Biochem Biophys ges Commun, 2000, 272(2); 357-361.
33. Oemar BS, Werner A, Garnier JM, et al. Human connective tissue growth factorIs expressedin advanced atherosolerotic lesions[J].Circulation, 1997, 95(4); 831-839.
34．顾天华，龚艳春，王德治，郭冀珍．高血压合并腔隙性脑梗死转移生长因子β1的变化．上海第二医科大学学报，2002，22(6)：515-517．
35．王钢，黄建群．脑卒中患者转化生长因子与细胞粘附因子检测及分析[J]．中华内科杂志，2000，39(5)；309-311．
36. Chen X, Ren S, Ma MG, et al. Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-beta in carotid artery of atherosolerotic rabbits[J]. Atherosolerosis, 2003, 169(1); 31-40.
37. Saiura A, Sata M, Hirata Y, et al. Tranilast inhibits transplant-associated coronary arteriosclerosis in a murine model of cardiac;transplantation[J]. Eur J Pharmacol, 2001, 433(2-3): 163-168.
38. Meng X, Mavromatis K, Galls ZS.Mechanical stretching of human saphenous vein grafts induces expression and activation of matrixdegrading enzymes associated with vascular tissue injury and repair. Experimental and molecular pathology, 1999, 66(3); 227-228.
39. Rubanyi GM, Frey AD, KauserK, et al. Mechanoreception by the endothelium: mediators and mechanisms of pressure-and flow-induced vascular response. Blood Vessels, 1990, 27: 246.
40. Dostal DE, Hunt RA, Kule CE, et al. Molecular mechanisms of an giotension Ⅱ in modulating cardiac function intracardiac effects and signal transduction pathways[J]. MolCell cardiol, 1997, 29; 2893.
41. Lehxm ann E, et al. Microglia and macrophages axe major sources of locally proced transforming growth factor-betal after transient middle cerebral artery occlusion in rats. Glia, 1998, 24(4); 437-438.
42．中风病证候学与临床诊断的研究科研协作组．《中风病证候诊断标准》的临床验证研究．北京中医药大学学报，1994，17(6)；41-43．
43．徐理纳．关于活血化瘀药研究途径的概况．中医杂志，1981，22(7)；75．
44．黄庆仪，谌剑飞，马雅玲．急性缺血性中风气虚证与TNF-α，IL-6的相关性探讨．吉林中医药，2001，(3)；4-5．
45．谌剑飞，关少侠，李创鹤，张萍．糖尿病缺血性中风证候特征与神经内分泌免疫网络、脑病理改变的关系研究．放射免疫学杂志，2000，13(3)：143-145．
1．田金州，韩明向，涂晋文，杨承芝，杨惠民，邹忆怀，刘垣．《血管性痴呆的诊断、辨证及疗效评价标准》．北京中医大学学报，2001，23(5)；24-30．
2．郭改会，傅仁杰．170例中老年急性脑梗死证候特点分析．安徽中医学院学报，2002，21 (6)；58-60．
3．郭忠，韩明向，周宜轩，郭幸福．300例高黏综合征临床证候学调查与分析．中医药临床杂志，2006，18(4)；335-337．
4．高渝军，李荣亨，覃乔静．血FDP，D-二聚体与气虚血瘀证．四川省卫生管理干部学院学报，2001，20(4)；249-250．
5．吴大梅，冯麟，杨爱国，冯济凤．从五脏病机浅谈血癖证的形成．贵阳中医学院学报，2006，28(3)；6-7．
6．武留信，吕敏，师绿江，史平，康晟，宋蕾，任福秀，石英玲，刘广莉，武阳丰．1202例中老年人颈动脉硬度及相关因素研究．中华心血管病杂志，2004，32(8)；723-728．
7．朱文华，方力争，孟文芳，陈建华．急性心脑血管事件与代谢综合征的相关性研究．中华急诊医学杂志，2006，15(2)；168-170．
8. Wallace AM, Mc Mahon AD, Packard CJ, et al. Plasma leptin and her risk of cardiovaccular disease in the west of Scotland coronary prevention study [J]. Circulation, 2001, 104 (25); 39052-39056.
9．施小梅，俞茂华，吴晓琰，黄延焱．老年人群代谢综合征与脑血管病的相关分析．中国临床神经科学，2004，12(1)；66-68．
10．顾东风，黄广勇，吴锡桂，段秀芳．中国人群体重指数及其与心脑血管病的关系．中华医学杂志，2002，82(15)；1018-1021．
11. Jacob C. Seidell, W. M. Monique Verschuren, Edith M. Vanheer, et al. Over weight, under weight, and mortality. A Prospective Study of 48287 men and women. Arch Intern Med, 1996, 156; 958-936.
12．左秀美，邬英全．脑血管病死亡与体重指数及胆固醇相关性的研究．牡丹江医学院学报，2004，25(2)；1-3．
13．王坤玲，王魁亮，郭军．代谢综合征中医证型与胰岛素抵抗的关系．新疆中医药，2006，24(5)；25-28．
14．陈贵海，陈利国．肥胖与血瘀证形成的相关性研究．山东中医药大学学报，2002，26(2)；129-131．
15．周志焕．痰瘀并治法对单纯性肥胖大鼠治疗作用的实验研究．河北中医，2006，28(3)； 221-223．
16．吴启锋，熊尚全，温茂祥，杨永东，兰东辉．高血压病中医证型与盐敏感性及体重的关系．中国中西医结合杂志，2002，22(11)；865．
17．余学庆，李建生、庆慧．中风病证候影响因素的研究．新中医，2003，35(11)；20-22．
18．阎蔚，刘敏，徐光华．中医辨证分型治疗脂肪肝对患者体重指数、腰臀围比及血糖血脂水平影响的临床研究．新中医，2006，38(6)；42-43．
1．田金州，韩明向，涂晋文，杨承芝，杨惠民，邹忆怀，刘峘．《血管性痴呆的诊断、辨证及疗效评价标准》．北京中医大学学报，2001，23(5)；24-30．
2．孙宁玲．高血压与脑卒中[J]．新医学，2003，34(3)；137-139．
3．王显，程永杰，袁丽荣，等．高血压病左心室肥厚的阴阳属性及其治疗[J]．吉林中医药，1997，17(6)；4．
4．杨传华，韩玉水，刘政．中医药逆转高血压左心室肥厚的理论探讨[J]．河北中医，1994，16(5)；1-2．
5．周文强，刘德桓，林惠琴，等．脑卒中中医证型与临床总体评价的相关性研究[J]．广西中医学院学报，2002，5(3)；24-26．
6．姚魁武，王阶，朱翠玲，武继涛，王恰如，王在意．不同疾病血瘀证量化诊断的比较研究．辽宁中医杂志，2006，33(11)；1381-1383．
7．洪永敦，黄衍寿，吴辉，陈宇鹏，李斐媛，莫鸿辉．冠心病中医证候与炎症因子关系的临床研究．广州中医药大学学报，2005，22(2)；81-86．
8. Shah PK. Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol Clin, 1999, 17; 270-281.
9. Ross R. Atherosclerosis--an inflammatory disease [J].N Engl J Med, 1999, 340; 115-126.
10. Ridker PM, Hennekens CH, Burning JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J].N Engl J Med, 2000, 342(12): 836-842.
11. Ridker PM, RifaiN, Stampfer M J, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men[J].Circulation, 2000, 101(15); 1767-1772.
12. Caligiuri G, Mcoletti A, Poirier B, et al. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. Clin Invest, 2002, 109(6); 745-753.
13．姚魁武，杨戈，王阶．高血压病血瘀证患者血液学指标判别分析．世界科学技术-中 医药现代化基础研究(World Science and Technology／Modernization of Traditional Chinese Medicine and Materia Medica)，2006，8(5)；30-42．
14．丘瑞香，罗致强，朱雅宜，秦鉴．冠心病血瘀证血液理化特性与中医证型相关性研究．中医杂志，2002，43(5)；378-379．
15．丁邦晗，严夏，林晓忠，李松．血脂异常与胸痹心痛基本证型的相关性分析．辽宁中医杂志，2006，33(10)；1261-1262．
16．李松，丁邦晗，张敏州，蚁楷宏，邹旭，陈伯钧，林晓忠，刘泽银．365例胸痹心痛患者证型血脂分析．广州中医药大学学报，2005，22(2)；87-97．
17．顾衡强，陈美华，邹襄谷，吴松鹰，李永鉴，林求诚．老年高血压颈动脉硬化多因素中医证型分析．福建中医学院学报，2006，16(3)；7-10．
18．杨牧祥，于文涛，魏查，王长垠，王秉岳，安俊岐．缺血性中风患者证型分布规律的研究．中医药学刊，2006，24(9)；1593-1595．
19．张国平，刘华，别晓东．不同类型中风血瘀证患者血液流变学和凝血谱指标的研究．全科医学临床与教育，2006，4(3)；204-210．
20．张彦丽，邢秀吉，林求诚，田德禄．轻度脑动脉硬化症和脑梗塞血瘀证的相关性基础研究．中国中医基础医学杂志(Chinese J Basic Med TCM)，2001，7(6)；58-60．
21．邓常青，江劲波．脑梗塞患者凝血分子标记物变化与血瘀证的关系．中国中医基础医学杂志，1999，5(10)；58-60．
22．钟建，何立群，丁小强．146例慢性肾功能衰竭患者临床分型及相关生化指标研究．中医杂志，2006，47(5)；373-377．
23．陈志伟．慢性肾功能衰竭中医辨证分型与实验室检查的关系．中西医结合杂志，1998，8(7)；395．
1．田金洲，韩明向，涂晋文，杨承芝，杨惠民，邹忆怀，刘垣．《血管性痴呆的诊断、辨证及疗效评价标准》．北京中医大学学报，2001，23(5)；24-30．
2．易兴阳，袁光固，周东，等．脑梗死患者周围血细胞因子研究[J]．中风与神经疾病杂志，1996，13(6)；333-335．
3．易兴阳，潘继豹，池丽芬，陈存木，袁光固．进展性缺血性脑卒中患者细胞因子及黏附分子的研究．中国神经免疫学和神经病学杂志，2006，13(3)；169-172．
4．叶心国，李承晏，毛善平．急性脑梗死患者血清TNF-α、IL-1β和sICAM-1含量变化．中华急诊医学杂志，2003，12(1)；32-34．
5．王建茹，冯忠军，李娜，曹志坤．急性脑梗塞患者血IL-1、IL-6、TNF、TM水平的变化及临床意义．中国免疫学杂志，2004，20(6)；431-432．
6. Robert MF, Valeria G, Hideaki H, et al .Expression of a dominant negative of interleukirrlp converting enzyme in transgenic mice prevents neuronal cell death induced by tropic fator withdrawal and ischemic brain injury[J]. EXP Med, 1997, 185: 933-940.
7. Frank CB, Raymond F W, Patricia AS, et al. Ischemic preconditioning and brain tolerance[J]. Stroke, 1998, 29: 1937-1951.
8. Clearfield MB. C-reactive protein: a new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc, 2005, 105(9): 409-416.
9．骆杰伟，陈慧，吴小盈，兰健姿，邱志洁，严晓华，张雪梅．高血压病血瘀证患者高敏C反应蛋白的临床分析．中国中西医结合杂志，2006，26(7)；648-650．
10. Emsley HC, Smith CJ, Grain CM, et al. An early and substained per pheral inflammatory response in acute ischemic stroke:relationship with infection and atherosclerosis [J].J Neuroimmunol, 2003, 139(1-2): 93-101.
11．禹爱梅，邹玉安．急性脑梗死患者血清中IL-1β及IL-6水平变化的研究．河北北方学院学报，2006，23(2)；38-39．
12．曹姣妃，刘宁，梁德胜，裴世澄．急性脑血管病患者血清hs-CRP，TNF-α和IL-6的动态变化及临床意义．第四军医大学学报，2004，25(2)：173-175．
13．陈品 洪丽 邓建中．脑梗死患者血清TNF-α、IL-6含量的变化及意义．实用老年医学，2006，20(5)：57-59．
14. TezonoK, Sarker KP, Kikuchi H, et al. Bioactivity of the vascular endothelial growth factor trapped in fibrin clots: production of IL-6 and IL-8 in monocytes by fibrin clots [J]. Hae wpstasis, 2001, 31(2); 71-79.
15．杜凯音，董莉，孙喜山，李香玉．中风中医辨证分型与血清IL-6关系的研究．吉林中医药，2003，23(9)：5-6．
16．顾卫，谭峰，吴海科，王金良，黄涛．急性脑梗死辨证分型与细胞因子的关系．中国中西医结合急救杂志，2002，9(5)；302-304．
17．关少侠，谌剑飞，丁萍，等．急性缺血性中风始发状态风证与免疫细胞因子关系的研究[J]．深圳中西医结合杂志，2001，11(5)；266-268．
18．黄庆仪，谌剑飞，马雅玲，等．急性缺血性中风气虚证与TNF-a、IL-6的相关性探讨[J]．吉林中医药，2001，21(3)：4-5．
19．洪永敦，黄衍寿，吴辉，陈宇鹏，李斐媛，莫鸿辉．冠心病中医证候与炎症因子关系的临床研究．广州中医药大学学报，2005，22(2)；81-86．
20．姚魁武，王阶，朱翠玲，武继涛，王恰如，王在意．不同疾病血瘀证量化诊断的比较研究．辽宁中医杂志，2006，33(11)；1381-1383．
21. Intiso D, Zarrelli MM, Lagioia G, Di Rienzo F, Checchia De Ambrosio C, Simone P, Tonali P, Cioffi Dagger RP. Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol Sci, 2004 Feb, 24(6): 390-396.
22．毕国荣，卢丽萍，剑非．动态观察急性脑血管病患者血浆肿瘤坏死因子-α含量变化的临床意义．临床神经病学杂志，1999，12(2)；86-87．
23．黄作毅，韩凤，吴军．急性脑血管病患者血浆TNF，IL-6含量研究中风与神经疾病杂志，1999，16(2)：103-104．
24. Krupinski J, Kumar P, Kumar S, et al. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans[J]. Stroke, 1996, 27(5); 852-857.
25．程利萍，贾建民，濮孟久．IL-1β、TNF-α、TGF-β1与缺血性脑损害相关性研究．中国神经免疫学和神经病学杂志，2004，11(1)；36-38．
26．何志义，欧阳巅，张强，范红杰，房晓，吕昌龙．老年急性脑血管病患者细胞因子及其受体的研究．中华老年心脑血管病杂志，2001，3(5)；322-325．
27．王钢，黄建群．脑卒中患者转化生长因子与细胞粘附因子检测及分析[J]．中华内科杂志，2000，39(5)；309-311．
28．郭正良，傅毅，辛晓瑜，曾丽莉，沈介明，刘建荣，陈生弟．急性脑梗死患者ox-LDL、TGF-β1和VCAM-1的检测．上海交通大学学报(医学版)，2006，26(11)：1274-1276．
29. Lehxm ann E, et al. Microglia and macrophages axe major sources of locally proced transforming growth factor-betal after transient middle cerebral artery occlusion in rats. Glia, 1998, 24(4): 437-438.
30. Kawamata T, Ren J, Chan TC. Intracisternal osteogenic Protein-1 enhances functional recovery folowing foca stoke. Neuroreport, 1998, 9(7); 1441-1445.
31. Mallat Z, Gojova A, Marahiol-Fournigault C, et al. Inhibition of transforming growth factor-beta signaling accelerates atherosalerosis and induces an unstable plaque phenotype in mice[J].Circ Res, 2001, 89(10): 930-934.
32. Argmann(:A, Van Den Diepstraten CH, Sawyez CG, et al. Transforming growth factor-β1 inhibits macrophage aholesteryl ester accumulation induced by native and ox-idized VLDL remnants[J]. Arterioscler Throm Vasc Biol, 2001, 21(12): 2011-2018.
33. Saiura A, Sara M, Hirata Y, et al. Zranilast inhibits transplant-associated coronary arteriosclerosis in a murine model of cardiac;transplantation[J]. Eur J Pharmacol, 2001, 433(2-3): 163-168.
34. Chen X, Ren S, Ma MG, et al. Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-beta in carotid artery of atherosolerotic rabbits[J]. Atherosolerosis, 2003, 169(1): 31-40.
35．金惠铭，卢健，殷莲华．细胞分子病理生理学[M]．郑州大学出版社，2002，110-125．
36. Castellanos M, Castillo J, Garcia MM, et al.Inflammation mediated damage in progressing lacunar infarctions[J].Stroke, 2002, 33: 982-987.
37．袁肇凯，黄献平，谭光波，毛以林，卢芳国，胡志希，田松，李杰，孙贵香．冠心病血瘀证血管内皮细胞功能的检测分析．中国中西医结合杂志，2006，26(5)；407-410．
38．胡小勤，陈利国．血管内皮细胞粘附分子与血瘀证相关性探讨．陕西中医，2005，26(3)；249-250．
39. Wu Y, Zhu B D. Effect of Danggui Buxue Decoction on proliferation and expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells [J]. J West China Univ Med Sci (华西医科大学学报), 2001, 32 (4): 593-595.
40. Zhang Y J, Zhao L G, Wu X Z. Effect of Huoxuehuayu Decoction on expression of adhesive molecular of intrapulmonic endothelial cell of rats suffered from SAP [J]. Chin Tradit Herb Drugs(中草药), 2001, 32(11): 1010-1011.
41. Hao Y, Qiu Q Y, W J. Effect of astragalus polysaccharin(APS) on ymphocyte-endothelium adhesion and the molecular mechanism [J]. Immunnol J(免疫学杂志), 2000, 16(3): 206-209.
42．陈利国，屈援，葛红颖，胡小勤，聂优爱，何孟栖．补阳还五汤对血瘀证大鼠血管内皮细胞粘附分子表达的影响．Chinese Traditional and Herbal Drugs(中草药)，2005，36(5)；706-709．
43．李松，丁邦晗，张敏州，蚁楷宏，邹旭，陈伯钧，林晓忠，刘泽银．365例胸痹心痛患者证型与血脂分析．广州中医药大学学报，2005，22(2)；87-97．
44．邓丽娅，张印新．活血化瘀对血管内皮功能的影响．山东中医杂志，2006，25(11)；732-724
45. Tenglia AN, Buda AT, Wilkins RG, et al. Levels of expression of P-selection, E-selection and intercellular adhesion molecule-1 in coronary atherectomy specimens from patients with stable and unstable angia [J]. Am J Cardiol, 1997, 79(6); 742-747.
46. Ogawa H,Yasue H,Miyao Y, et al. Plasma soluble intercellular adhesion molecule-1 levels in coronary circulation in patients with unstable angina[J]. Am J Cardiol, 1999, 83(1); 38-42.
1. Jarskog LF, Gilmore JH. Developmental expression of Bcl-2 protein in human cortex. Brain Res Dev Brain Res, 2000, 119(2); 225-230.
2．廖维靖，Frank Wieg，Ulrich Dirnagl．脑缺血损伤的病理生理机制—损伤级联反应．国外医学脑血管疾病分册，1998，6(4)；197-202．
3. Olney J W. Brain lesion, obesity and other disturbances in mice treated with monosodium glutamate. Science, 1969, 164; 719-721.
4. Beal MF. Mechanisms of excitotoxicity in neuxologic diseases. FASEB J, 1992, 6(15); 3338-3344.
5. Greenamyre JT, Greene JG, Higgins DS, et al.Mechanism of selective neuronal vulnerability:Bioenergetics and excitotoxicity. In:Marwak J, Prasad KN, Teitelbaum H, eds. Neural Transplantation, CNS Neuronal Injury, and Regeneration. New York:CRC Press, 1994, 71-80.
6. Choi DW. Excitotoxic cell death. J Neurobiol, 1992, 23:1261-1276
7. Olney JW, Wozniak DF, Farber NB. Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies Arch Neurol, 1997, 54; 1234-1240.
8. Rice AC, Delorenzo RJ. NMDA receptor activation during status epilepticus is required for the development for epilepsy: Brain Res, 1998, 7820 (2); 240-247.
9. Castillo J, Davalos A, Noya M. Progression of ischemic stroke and excitotoxicity amino acids. Lancet, 1997, 349; 79-83.
10．贾建平．缺血性脑卒中病理生理．2003神经病学新进展[M]．第一版．北京：人民卫生出版社，2003，55-56．
11. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Eng J Med, 1994, 330; 613-622.
12. Tonumoto H, Takemoto O, Akiguchi I, et al. Immunoelectron microscopic study of c-Fos, c—Jun and beat shock protein after transient cerebral ischemia in gerbils I. J Acts. Neuropathol(Berl), 1999, 97(1); 22.
13 . Koistinaho 3, Hokfelt T. Altered gene expression in brain ischemic Neuroreport, 1997, 8(2); 1.
14. Astrup J, Symon L, Branston NM, et al. Cortical evoked potential and extracellular K+ and H+ at critical levels of brains ischemia. Stroke, 1977, 8; 51.
15. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol, 1994, 36(4); 557-565.
16. Hakim Am. Ischemic penumbra: the therapeutic window. Neurology, 1998, 51(suppl3): 844-846.
17. Grinvald A, Shoham D, Shmuel A, et al. In viva optical imaging of cortical architecture and dyna mics . I n:Windhorst U, Johansson H, ed. Modern Techniques in Neuroscience Research. Berlin:Springer, 1999, 893-969.
18. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol, 1999, 17(9); 2941-2953. Review.
19. Stennicke HR, Salvesen GS . Caspases - controlling intracellular signals by protease zymogen activation. Biochim Biophys Acta, 2000 Mar 7, 1477(1-2); 299-306. Review.
20. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 1994 Jun, 9(6); 1799-1805.
21. Petito CK, Torres-Munoz J, Roberts B, et al. DNA fragmentation follows delayed neuronal death in CA1 neurons exposed to transient global ischemia in the rat. J Cereb Blood Flow Metab, 1997 Sep, 17(9); 967-976.
22. Lindner V, Collins T. Expression of NF-κB and 1κB-aby aortic endothelaium in a arterial injury model[J] . Am J Pathol, 1996, 148; 472.
23. Pueyo ME, Gonzalez W, Mcoletti A, et al. Angiotensin 11 stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor kappa B activation induced by intracellular oxidative stress [J]. Arterioscler Thromb Vasc Biol, 2000, 20; 645-651.
24. Sandner P, Wolf K, Bergmaier U, et al . Hypoxia and cobalt stimulate vascular endothelial growth factor receptor gene expression in rats . Pflugers Arch, 1997, 433; 803-808.
25. Jiang BH, Rue E, Wang GL, et al. Dimerization, DNA binding, and transactivation properties of hy-poxia-inducible factor-1 . J Biol Chem, 1996, 271 ; 17771-17778.
26. Semenza GL, Agani F, Booth G, et al. Structural and functional analysis of hypoxia-inducible factor-1. Kid Int, 1997, 51; 553-555.
27. Liu PK, Grossman RG, Hsu CY, et al.Ischemic injury and faulty gene transcripts in the brain[J].Trends Neurosci, 2001, 24(10); 581-588.
28. Hue RI, Padmaja S.The reaction of NO with superoxide[J]. Free Radio Res Commun, 1998, 18(4); 195-199.
29. Sharp FR, Lu A, Tang Y, et al. Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab, 2000 Jul, 20(7); 1011-1032. Review.
30. Ruscher K, Isaev N, Trendelenburg G, et al. Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons. Neurosci Lett, 1998 Sep 25, 254(2); 117-120.
31. Stanimirovic DB, Wong J, Shapiro A, et al.Increase in surface expression of ICAM-1 and E-selectin in human cerebromicrovascular endothelial cells subjected to ischemia-like insults[J].Neurochi suppl wien, 1997, 70; 12-16.
32. Webster SD, Park M, Fonseca MI, et al, Structural and functional evidence for microglial expression of CloR(P), the Clq receptor that enhances phagocvtosis[J]. J Leukoc Biol, 2000, 67(1): 109-116.
33. Dawson VL, Dawson TM. Nitric oxide in neurodegeneration. Prog Brain Res, 1998, 118; 215-229.
34. Dong Y, Benveniste EN. Immune function of astrocytes. Glia, 2001, 36; 180-190.
35．张剑，田野苹．CNS中抗原递呈细胞调节T细胞对CNS抗原的应答．中国神经科学杂志，2002August，18(3)；639-642．
36. Touzani O, Boutin H, Chuquet J, et al. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroi m munol, 1999, 100; 203-215.
37. Zheng GZ, Michael C, Anton G. Cerebral vessels express interleukin-1β after focal cerebral ischemia[J].Brain Research, 1998, 784; 210-217.
38．狄政莉，万琪，来华安，王洪典．IL-1β和IL-6在脑缺血再灌注微血管内皮细胞炎症反应中的作用．西安医科大学学报，2001，22(5)；432-434．
39. Ding Y, Young CN, Li J, et al. Reduced inflammatory mediator expression by pre-reperfusion infusion into ischemic territory in rats: a real-time polymerase chain reaction analysis. Neuroscience Letters, 2003 Dec 26, 353(3); 173-176.
40．杜柏岩，关秀茹，高光强，等．IL-β对大鼠脑缺血再灌注损伤的意义．哈尔滨医科大学学报，2000，34(2)；124-125．
41．田金洲主编．《血管性痴呆》．人民卫生出版社，2003，259．
42. Thomas JD. The role of inflammation after acute stroke[J].Neurolgy, 1998, 51; s62-68.
43. Legos JJ, Whitmore RG, Erhardt JA, et al.Quantitative changes in interleukin in proteins following focal stroke in the ratf [J]. Neurosci lett, 2000, 282(3); 189-925.
44. Block F,Peters M, Nolden- Koch M.Expression of IL-6 in the ischemic penumbra[J].Neuroreport, 2000, 11(5); 963-967.
45. Loddick SA, Turnbull AV, Rothwell NJ.Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat[J].lereb Blood Flow Metab, 1998, 18; 176-179.
46. Barone FC, Arvin B, White RE, et al. Tumor necrosis factor alpha:A mediator of focal ischemic brain injury. Stroke, 1997, 28; 1233-1244.
47. Jean WC, Spellman SR, Nussbaum ES, et al. Reperfusion injury after focal cerebral ischemia:the role of inflammation and the therapeutic horizon. Neurosurgery, 1998, 43; 1382-1397.
48. Buttini M, Appel K, Sauter A, et al. Expression of tumor necrosis factor alpha after focal cerebral ischemia in the rat[J]. Neuroscience, 1996, 71; 1-16.
49．张莉莉，王景周，周华东，陈曼娥．肿瘤坏死因子-α在大鼠脑缺血再灌注损伤中的作用机制．中华老年医学杂志，2003年，22(2)；102-104．
50．胡建鹏，王键，郜峦，等．局灶性脑缺血再灌注时神经元、胶质细胞形态变化与TNF-α表达相关的实验研究．中国病理生理杂志，2004，20(7)：1251-1255．
51．张玲，余绍祖，吴国祥．大鼠脑缺血再灌注后TNF-α，IL-β及细胞间粘附分子-1mRNA的表达．卒中与神经疾病，2001，8(2)；77-79．
52. Lehxm ann E, et al. M icroglia and macrophages are major sources of locally proced transforming growth factor-betal after transient middle cerebral artery occlusion in rats. Glia, 1998, 24(4); 437-438.
53．刘士民，郭玉璞．大鼠局灶脑缺血／再灌注模型TGTβ的表达．基础医学与临床，2000，20(1)；70-73．
54．王社军，蒋传路，康军，胡韶山，李永力，葛云龙，杨立庄，戴有利．大鼠脑缺血／再灌注后血脑屏障通透性的改变及转移生长因子β1的表达．中华神经外科杂志，2003，19(1)；51-54．
55. Wang XK, Yue T, White TF, et al. Transforming growth factor beta-i exhibits delayed gene expression following focal cerebral ischem ia. Brain Res Bull, 1995, 36(6); 607-609.
56. Clark WM, Lauten JD, Lessov N, et al. Time course of ICAM-1 expression and leukocyte subset infiltration in rat forehrain ischemia. Mol Chem neurophathol, 1995, 26; 213.
57. Kacimi R, Karliner JS, Koudssi F, et al. Expression and regulation of adhesion molecules in Cardiac cells by cytokines response to acute hypoxia[J].Circ Res, 1998, 82(5); 576-586.
58. Dixon GL, Heyderman RS, van der Ley P, et al.High-level endothelial F selectin(CD62E) cell adhesion molecule expression by a lipopolysaccharide-deficient strain of Neisseria meningitidis despite poor activation of NF-kappaB transcription factor[J].Clin Exp Immunol, 2004, 135(1); 85-93.
59. Argenbright L W, Barton R W. Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo.The Shwartzman reaction revisited[J] Clin Invest, 1992, 89(1); 259-272.
60．崔尧元，余勇，张晓彪，刘银坤．细胞间粘附分子1、肿瘤坏死因子α转录水平在缺血再灌注大鼠脑皮质中表达的相关性．中华实验外科杂志，1999，16(5)；442-443．
61．葛海良，Wen Ye，Guo-Yuan Yang，A．Lorris Betz．小鼠局灶性脑缺血模型中细胞间粘附分子-1表达升高．中国神经免疫学和神经病学杂志，1999，6(3)；147-152．
62. Zhang RL, Chopp M, Zaloga C, et al. The temporal profiles of ICAM-1 protein and Mrna expression after transient MCA occlusion in the rat. Brain Res, 1995, 682; 182.
63. Yang GY, Gong C, Qin Z, et al. Inhibition of TNF-α attenuate infarct volume and ICAM-1 expression in ischemic mouse brain. Neuro Report, 1998, 9; 2131.
64. Yang GY, Mao Y, Zhou LF, et al. Attenuation of temporary focal cerebral ischemic injury in the mouse following transfection with IL-1 receptor antagonist. Brain Res Mol Brain Res, 1999, 72; 129.
65. De Graba TJ. The role of inflammation after acute stroke:utility of put suinganti-adhesion molecule therany. Neuroloey, 1998, 51; S62.
66. Yang GY, Schielke GP, Gong C, et al. Expression of TNF-α and ICAM-1 after focal cerebral ischemia in IL-1β converting enzyme deficient mice. J Cereb Blood Flow Metab, 1999, 19; 1109.
67. Schroeter M, Eury P, Jander S. Inflammatory gene expression in focal cortical brain ischemia: differences between rats and mice. Brain Res Mol Brain Res, 2003 Sep 10, 117(1); 1-7.
68．钟照华，李国忠，李呼伦，等．人缺血脑组织中TNF-α和IL-1β的表达．细胞与分子免疫学杂志(Chin J Cell Mol Immunol)，2003，19(4)；349-363．
69. Tarkowski E, Rosengren L, Blomstrand C, et al. Early intrathecal production of interleukin-6 predicts the volume of brain lesion in stroke[J].Stroke, 1995, 26; 1393-1398.
70．易兴阳，袁光固，周东，等．脑梗死患者周围血细胞因子研究[J]．中风与神经疾病杂志，1996，13(6)；333-335．
71．易兴阳，潘继豹，池丽芬，陈存木，袁光固．进展性缺血性脑卒中患者细胞因子及黏附分子的研究．中国神经免疫学和神经病学杂志，2006，13(3)；169-172．
72．禹爱梅，邹玉安．急性脑梗死患者血清中IL-1β及IL-6水平变化的研究．河北北方学院学报，2006，23(2)；38-39．
73．叶心国，李承晏，毛善平．急性脑梗死患者血清TNF-α、IL-1β和sICAM-1含量变化．中华急诊医学杂志，2003，12(1)；32-34．
74．王建茹，冯忠军，李娜，曹志坤．急性脑梗塞患者血ILI、IL6、TNF、TM水平的变化及临床意义．中国免疫学杂志，2004，20(6)；431-432．
75. Robert MF, Valeria G, Hideaki H, et al.Expression of a dominant negative of interleukirrlp converting enzyme in transgenic mice prevents neuronal cell death induced by tropic fator withdrawal and ischemic brain injury[J]. EXP Med, 1997, 185; 933-940.
76. Frank CB, Raymond F W, Patricia AS, et al. Ischemic preconditioning and brain tolerance[J].Stroke, 1998, 29; 1937-1951.
77. Emsley HC, Smith CJ, Grain CM, et al. An early and substained per pheral inflammatory response in acute ischemic stroke:relationship with infection and atherosclerosis [J].J Neuroimmunol, 2003, 139(1-2); 93-101.
78．曹姣妃，刘宁，梁德胜，裴世澄．急性脑血管病患者血清hs-CRP，TNF-α和IL-6的动态变化及临床意义．第四军医大学学报，2004，25(2)；173-175．
79. TezonoK, Sarker KP, Kikuchi H, et al Bioactivity of the vascular endothelial growth factor trapped in fibrin clots: production of Ih-6 and IL-8 in monocytes by fibrin clots [J]. Hae wpstasis, 2001, 31(2); 71-79.
80．陈品 洪丽 邓建中．脑梗死患者血清TNF-α、IL-6含量的变化及意义．实用老年医学，2006，20(5)；57-59．
81. Intiso D, Zarrelli MM, Lagioia G, Di Rienzo F, Checchia De Ambrosio C, Simone P, Tonali P, Cioffi Dagger RP. Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol Sci, 2004 Feb, 24(6): 390-396.
82．毕国荣，卢丽萍，剑非．动态观察急性脑血管病患者血浆肿瘤坏死因子-α含量变化的临床意义．临床神经病学杂志，1999，12(2)；86-87．
83．黄作毅，韩凤，吴军．急性脑血管病患者血浆TNF-α，IL-6含量研究中风与神经疾病杂志，1999，16(2)；103-104．
84. Krupinski J, Kumar P, Kumar S, et al. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans[J]. Stroke, 1996,27(5);852-857.
85．王钢，黄建群．脑卒中患者转化生长因子与细胞粘附因子检测及分析[J]．中华内科杂志，2000，39(5)：309-311．
86．顾天华，龚艳春，王德治，郭冀珍．高血压合并腔隙性脑梗死转移生长因子β1的变化．上海第二医科大学学报，2002，22(6)；515-517．
87．程利萍，贾建民，濮孟久．IL-1β、TNF-α、TGF-β1与缺血性脑损害相关性研究．中国神经免疫学和神经病学杂志，2004，11(1)；36-38．
88．何志义，欧阳巅，张强，范红杰，房晓，吕昌龙．老年急性脑血管病患者细胞因子及其受体的研究．中华老年心脑血管病杂志，2001，3(5)；322-325．
89．郭正良，傅毅，辛晓瑜，曾丽莉，沈介明，刘建荣，陈生弟．急性脑梗死患者ox-LDL、TGF-β1和VCAM-1的检测．上海交通大学学报(医学版)，2006，26(11)：1274-1276．
90. Kawamata T, Ren J, Chan TC. Intracisternal osteogenic Protein-1 enhances functional recovery folowing foca stoke. Neuroreport, 1998, 9(7): 1441-1445.
91. Castellanos M, Castillo J, Carcia MM, et al. Inflammation mediated damage in progressing lacunar infarc-tions[J]. Stroke, 2002, 33: 982-987.
1．翁为良主编．《活血化瘀治疗疑难病》．学苑出版社，2003年，第2版．
2．国家技术监督局．中华人民共和国国家标准．中医病证分类与代码．中医证候名称与分类代码，北京：中国标准出版社，1995，1．
3．国家技术监督局．中华人民共和国国家标准．中医临床诊疗术语证候部分．北京：中国标准出版社，1997，1．
4．国家中医药管理局．中华人民共和国中医药行业标准．中医病证诊断疗效标准，南京：南京大学出版社，1994，1．
5．中国中西医结合研究会老年病专业委员会．中医虚症辨证参考标准．中西医结合杂志，1986，6(10)：598．
6．中西医结合心血管学会．冠心病中医辨证标准．中西医结合杂志，1991，11(3)；257．
7．1980年全国冠心病辨证论治研究座谈会．冠心病(心绞痛，心肌梗塞)中医辨证试行标准．中医杂志，1980，21(8)；46．
8．中华全国中医学会内科学会．中风病中医诊断、疗效评定标准．中国医药学报，1986，1(2)：56-57．
9．中西医结合学会心血管学会．冠心病中医辨证标准．中西医结合杂志，1991，11(5)：129．
10．中国中医药学会消渴病专业委员会．消渴病(糖尿病)中医分期辨证与疗效评定标准．中国医药学报，1993，8(3)：54．
11．田金州，韩明向，涂晋文等，血管性痴呆诊断、辨证及疗效评定标准(研究用)．中国老年学杂志，2002，5；56-60．
12．国家中医药管理局脑病急症科研组．中风病辨证诊断标准(试行)．北京中医药大学学报，1994，17(11)；64-65．
13．国家中医药管理局脑病急症科研组．中风病诊断与疗效评定标准的临床验证报告．北京中医药大学学报，1996，19(1)；57-59．
14．中国中西医结合研究第一次全国活血化瘀学术会议．血瘀证诊断试行标准[S]．西医结合杂志，1983，3(3)；封二．
15．第二届全国活血化瘀研究学术会议修订血瘀证诊断标准．1986年11月，广州．
16．李先涛，赖世隆，梁为雄．运用循证医学对血瘀证诊断标准研究文献的评价．广州中医药大学学报，2003，20(2)；168-170．
17．吴承玉．血瘀证的研究发展脉络与评述．南京中医药大学学报，2004，20(3)；133-136．
18．王阶，陈可冀，翁维良，钱振淮，王怡，刘剑刚，葛争艳．血瘀证诊断标准的研究．中西医结合杂志，1988，8(10)；585-589．
19．王阶，姚魁武．血瘀证诊断标准研究述要及思考．中国中医药信息杂志，2004，11(1)；17-19．
20．中西医结合学会活血化瘀专业研究会．血瘀证诊断标准[S]．中西医结合杂志，1987，7(3)：129．
21．姚魁武，王阶，朱翠玲，武继涛，王恰如，王在意．不同疾病血瘀证量化诊断的比较研究．辽宁中医杂志，2006，33(11)；1381-1383．
22．朱文锋，吴润球，瞿岳云．中医诊断的特色和优势．湖南中医学院学报，2000，(20)3：40-42．
23．中国中医药学会内科学会消渴病专业委员会1992．消渴病(糖尿病)中医分期辨证与疗效评定标准．中国医药学报，1993，8(3)；54-56．
24．国家中医药管理局脑病急症科研组．中风病辨证诊断标准(试行)．北京中医药大学学报，1991，17(3)；64-66．
25．1996年度国家中医药管理局中医药基础研究奖奖励项目．中国中医药科技，1997，4(5)：299．
27．中风病证候学与临床诊断的研究科研协作组．《中风病证候诊断标准》的临床验证研究．北京中医药大学学报，1994，17(6)；41-43．
28．章桂康．中风病中医诊断疗效评定标准．中医杂志，1992，4；39．
29．陈文为．中药新药临床研究指导原则．第1辑．第1版．北京：人民卫生出版社，1993，116-118．
30．彭世洪．急性脑梗塞的中医分型与CT影像的关系．衡阳医学院学报，1999，27(1)：50-51．
31．王顺道，任占利，杜梦华，解庆凡，贾滋欣，王永炎．中风病始发态证候与脑病理改变相关关系的研究．中国中医急症，1999，8(1)；36-39．
32．王玉来，郑慧，刘文娜．中风急症证候分析．中国中医急症，1995，4(2)；74-79．
33．梁伟雄，温泽淮，赖世隆，莫传伟，黄培新，刘茂才，王奇．中风病中医证候特征与脑病理改变的相关关系研究．新中医，1999，31(7)；41-42．
34．梁伟雄，赖世雄，刘茂才，莫传伟，黄培新，温泽淮，王奇，陈云波．中风病中医证候与相关因素分析．广州中医药大学学报，1999，16(2)；81-84．
35．郭改会，傅仁杰．170例中老年急性脑梗死证候特点分析．安徽中医学院学报，2002，21(6)：35-37．
36．余学庆，李建生，庆慧．中风病证候影响因素的研究．新中医，2003，35(11)；20-22．
37．王顺道，司志国，黄宜兴，等．中风病证候的初步研究．中国中医急症，1995，4(2)；85-88．
38．王新志，韩群英，陈贺华主编．中华实用中风病大全．第1版．北京：人民卫生出版社，1996，1044-1048．
39．谌剑飞，关少侠，丁萍，李创鹏，梁浩荣，马雅玲，奚玉风，杨慧珊，蔡绍华，张艳玲，徐进华．中风急症证候研究与问题探讨．中国中西医结合急救杂志，2001，8(3)；169-171．
40．杨牧祥，于文涛，魏萱，王长垠，王秉岳，安俊岐．缺血性中风患者证型分布规律的研究．中医药学刊，2006，24(9)；1593-1595．
41．谌剑飞，关少侠，李创鹏，张萍．糖尿病缺血性中风证候特征与神经内分泌免疫网络、脑病理改变的关系研究．放射免疫学杂志，2000，13(3)；143-145．
42．刘健，戴慧寒，梁耀基，邱文克．广东顺德地区急性脑梗死患者中医证候与牛津郡社区卒中项目分型的相关性．中国临床康复，2005，9(21)；152-154．
43．周慎，易振佳，刘伍立，赵艳玲，岳增辉，王淑云，赵瑞成，蒋荣鑫，杨玉龄．757例中风后遗症中医证候与中风主症的相关性分析．湖南中医药导报，2003，9(8)；11-13．
44．王建华，王永炎．出血性中风、缺血性中风急性期证候演变规律的研究．中国中医急症，2001，10(4)；215-217．
45．杨利，黄燕，蔡业峰，杜宝新，陈红霞，卢明，黄培新．1418例中风患者痰瘀证候分布和演变规律探析．辽宁中医杂志，2004，31(6)；459-460．
46．郑筱萸主编．中药新药临床研究指导原则[S]．北京：中国医药科技出版社，2002，99-104．
47．陈贵廷，薛赛琴．最新国内外疾病诊疗标准[M]．北京学苑出版社，1992，650-654．
48．王永炎．完善中医辨证方法体系的建议．中医杂志，2004，45(10)；729-731．
49．赵连根．研究活血化成必须研究组织氧供[J]．中国中西医结合杂志，1992，12(12)；747．
50．俞征宙，方素钦，余启胜．中风病中医辨证分型与免疫功能变化的关系[J]．福建中医药，2000，31(3)：3-5．
51．杜凯音，董莉，孙喜山，李香玉．中风中医辨证分型与血清IL-6关系的研究．吉林中医药，2003，23(9)；5-6．
52．顾卫，谭峰，吴海科，王金良，黄涛．急性脑梗死辨证分型与细胞因子的关系．中国中西医结合急救杂志，2002，9(5)；302-304．
53．关少侠，谌剑飞，丁萍，等．急性缺血性中风始发状态风证与免疫细胞因子关系的研究[J]．深圳中西医结合杂志．2001：11(5)：266-268．
54．黄庆仪，谌剑飞，马雅玲，等．急性缺血性中风气虚证与TNF-a、IL-6的相关性探讨[J]．吉林中医药，2001，21(3)；4-5．
55．王艳芬，毕丽丽．腔隙性脑梗死中医辨证分型规律的探讨[J]．中医药信息，2001，18(3)；5．
56．张明，丁向东，魏国，等．中风病人不同证型全血SOD和血浆TXB2的相关性研究[J]．山东中医药大学学报，1998，22(5)；349-352．
57．顾卫，杨东，吴海科，等．脑血栓血瘀证患者血浆组织型纤溶酶原激活剂、纤溶酶原激活剂抑制物和α-颗粒膜蛋白含量变化的研究．中西医结合实用临床急救，1998，5(2)：52．
58．林松波，连棋周，庞明．急性脑梗塞中医辨证分型血管内皮细胞活行因子检测证的指标探讨．中国中西医结合杂志，2000，20(12)；911．
59．胡庆全．脑梗塞中医证型与微循环关系研究．中国微循环，2001，5(4)；306-307．
60．覃乔静，李荣亨．气虚血瘀证血浆NPY、ET、CGRP的改变及相关性研究．重庆医科大学学报，2003，28(2)；202-204．
61．姜春华．活血化瘀研究．上海：上海科技出版社，1981，41-113．
62．周活，田维君．100例气虚血瘀证血液流变学研究．武警医学，1990，7(6)；349．
63．吴汉卿，黄召谊，杨芙蓉．老年气虚血瘀证患者微循环和血液流变学特征及通心络胶囊的治疗作用．微循环学杂志，2004，14(2)；13-15．
64．张国平，刘华，别晓东．不同类型中风血瘀证患者血液流变学和凝血谱指标的研究．全科医学临床与教育，2006，4(3)；204-210．
65．孔令钧，李光华，李鲁扬．老年血瘀证与细胞黏附分子关系的探讨．山东中医药大学学报，2003，27(4)；274-276．
66．邓常青，江劲波．脑梗塞患者凝血分子标记物变化与血瘀证的关系．中国中医基础医学杂志，1999，5(10)；121．
67．林松波，陈健，梁晖，等．中风恢复期中医辨证分型与氧自由基脂质过氧代谢及微量元素的关系[J]．中医药学报，2000，2；53-55
68．马卫琴，陈皆乐，李小春，等．中风病中医辨证分型与抗氧化酶关系探讨[J]．中国中 医基础医学杂志，1999，5(10)；39-40．
69. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med, 1999, 340; 115-120.
70．时晶，田金洲，王永炎，朱爱华，尹军祥，武月萍，徐意．血瘀证的生物学基础研究．中华中医药杂志，2006，21(6)；363-364．
2．王阶，陈可冀，翁维良，钱振淮，王怡，刘剑刚，葛争艳．血瘀证诊断标准的研究．中西医结合杂志，1988，8(10)；585-589．
3．王兆钱．血栓相关性疾病的临床流行病学．中华医学杂志，2004，84(5)；432-434．
4．吴承玉．血瘀证的研究发展脉络与评述．南京中医药大学学报，2004，20(3)；133-136．
5．高启龙，闫晓天．糖尿病肾病从瘀论治临床研究进展．河南中医学院学报，2004，19(111)；84-86．
6．谌剑飞．糖尿病缺血性中风中医证型与血清炎症细胞因子关系的研究．中国中西医结合急救杂志，2000，7(3)；147-149．
7．陈云波，王奇，赖世隆．从血管内皮细胞功能改变看血瘀证实质及活血化瘀机理[J]．中国中医基础医学杂志，1996，2(1)；37-38．
8．雷燕，黄启福，王永炎．论瘀毒阻络是络病形成的病理基础[J]．北京中医药大学学报，1999，22(2)；8-9．
9．郑萍．血栓闭塞性脉管炎患者血瘀证的血液学指标探讨[J]．中西医结合杂志，1986，6(6)；332-333．
10. Saito K, Suyam a K, Nishida K, et al. Early increases in TNF-α, IL6 and IL1 β levels following transient cerebral ischemia in gerbil brain. NeurosciLett, 1996, 206(2): 149-150.
11. Mathiesen T, Andersson B, Loftenius A, et al. Inereased interleakin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg, 1993, 78(4): 562.
12. SchettniG, Grimalai M, Landilfie, et al. Role of interleakin-6 in the neuroendocrine system. Acta Neurol, 1991, 24(13): 316.
13. Touzani O, Boutin H, Chuquet J, et al. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol, 1999, 100: 203-215.
14. Zheng GZ, Michael C, Anton G. Cerebral vessels express interleukin-1β after focal cerebral ischemia[J].Brain Research, 1998, 784: 210-217.
15. Nikolaos K, Pia K, Yumin H, et al. Ische mia stroke is associated with a systemic increase of blood mononuclear cells expressing interleukirr8 mRNA[J]. Stroke, 1998, 29; 462-466.
16. Zhai QH, Futrell N, Hen FJ.Gene expression of IL-10 in relationship to TNF-alpha, IL-1 beta and IL-2 in the rat brain following middle cerebral artery occlusion[J].Neurol Sci, 1997, 152: 119-124.
17. Buttini M, Appel K, Sauter A, et al.Expression of tumor necrosis factor alpha after focal cerebral ischemia in the rat[J]. Neuroscience, 1996, 71; 1-16.
18．毕国荣，卢丽萍，剑非．动态观察急性脑血管病患者血浆肿瘤坏死因子-α含量变化的临床意义．临床神经病学杂志，1999，12(2)；86-87．
19．黄作毅，韩凤，吴军．急性脑血管病患者血浆TNF、IL-6含量研究中风与神经疾病杂志，1999，16(2)：103-104．
20. Lehxm ann E, et al. Microglia and macrophages are major sources of locally proced transforming growth factor-betal after transient middle cerebral artery occlusion in rats. Glia, 1998, 24(4); 437-438.
21. Krupinski J, Kumar P, Kumar S, et al. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans[J]. Stroke, 1996, 27(5); 852-857.
22. Intiso D, Zarrelli MM, Lagioia G, Di Rienzo F, Checchia De Ambrosio C, Simone P, Tonali P, Cioffi Dagger RP. Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol Sci, 2004, 24(6); 390-396.
23. Robert MF, Valeria G, Hideaki H, et al.Expression of a dominant negative of interleukirrlp converting enzyme in transgenic mice prevents neuronal cell death induced by tropic fator withdrawal and ischemic brain injury[J]. EXP Med, 1997, 185; 933-940.
24. Frank CB, Raymond F W, Patricia AS, et al. Ischemic preconditioning and brain tolerance[J].Stroke, 1998, 29; 1937-1951.
25. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/ macro-phages in the pathogenesis of cerebral ischemia and stroke. Stroke, 1992,23; 1367.
26．杨金升．肿瘤坏死因子在脑卒中时的表达及应用．国外医学脑血管疾病分册，1996，4(2)；77-80．
27. Thomas JD. The role of inflammation after acute stroke[J].Neurolgy, 1998, 51; s62-s68.
28. Loddick SA, Turnbull AV, Rothwell NJ.Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat[J].Cerebral Blood Flow Metab, 1998, 18; 176-179.
29. Mallat Z, Gojova A, Marahiol-Fournigault C, et al. Inhibition of transforming growth factor-beta signaling accelerates atherosalerosis and induces an unstable plaque phenotype in mice[J]. Circ Res, 2001, 89(10); 930-934.
30. Argmann (:A, Van Den Diepstraten CH, Sawyez CG, et al. Transforming growth factor-β1 inhibits macrophage aholesteryl ester accumulation induced by native and ox-idized VLDL remnants[J]. Arterioscler Throm Vasc Biol, 2001, 21(12); 2011-2018.
31. Zuckerman SH, Panousis C, Evans G. TOF-beta reduced binding of high-density lipoproteins in murine macrophages and macrophage derived foam cells[J]. Atherosclerosis, 2001, 155(1); 79-85.
32. Minami M, Knme N, Kataoka H, et al. Transforming growth factor-beta(1) increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 [J]. Biochem Biophys ges Commun, 2000, 272(2); 357-361.
33. Oemar BS, Werner A, Garnier JM, et al. Human connective tissue growth factorIs expressedin advanced atherosolerotic lesions[J].Circulation, 1997, 95(4); 831-839.
34．顾天华，龚艳春，王德治，郭冀珍．高血压合并腔隙性脑梗死转移生长因子β1的变化．上海第二医科大学学报，2002，22(6)：515-517．
35．王钢，黄建群．脑卒中患者转化生长因子与细胞粘附因子检测及分析[J]．中华内科杂志，2000，39(5)；309-311．
36. Chen X, Ren S, Ma MG, et al. Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-beta in carotid artery of atherosolerotic rabbits[J]. Atherosolerosis, 2003, 169(1); 31-40.
37. Saiura A, Sata M, Hirata Y, et al. Tranilast inhibits transplant-associated coronary arteriosclerosis in a murine model of cardiac;transplantation[J]. Eur J Pharmacol, 2001, 433(2-3): 163-168.
38. Meng X, Mavromatis K, Galls ZS.Mechanical stretching of human saphenous vein grafts induces expression and activation of matrixdegrading enzymes associated with vascular tissue injury and repair. Experimental and molecular pathology, 1999, 66(3); 227-228.
39. Rubanyi GM, Frey AD, KauserK, et al. Mechanoreception by the endothelium: mediators and mechanisms of pressure-and flow-induced vascular response. Blood Vessels, 1990, 27: 246.
40. Dostal DE, Hunt RA, Kule CE, et al. Molecular mechanisms of an giotension Ⅱ in modulating cardiac function intracardiac effects and signal transduction pathways[J]. MolCell cardiol, 1997, 29; 2893.
41. Lehxm ann E, et al. Microglia and macrophages axe major sources of locally proced transforming growth factor-betal after transient middle cerebral artery occlusion in rats. Glia, 1998, 24(4); 437-438.
42．中风病证候学与临床诊断的研究科研协作组．《中风病证候诊断标准》的临床验证研究．北京中医药大学学报，1994，17(6)；41-43．
43．徐理纳．关于活血化瘀药研究途径的概况．中医杂志，1981，22(7)；75．
44．黄庆仪，谌剑飞，马雅玲．急性缺血性中风气虚证与TNF-α，IL-6的相关性探讨．吉林中医药，2001，(3)；4-5．
45．谌剑飞，关少侠，李创鹤，张萍．糖尿病缺血性中风证候特征与神经内分泌免疫网络、脑病理改变的关系研究．放射免疫学杂志，2000，13(3)：143-145．
1．田金州，韩明向，涂晋文，杨承芝，杨惠民，邹忆怀，刘垣．《血管性痴呆的诊断、辨证及疗效评价标准》．北京中医大学学报，2001，23(5)；24-30．
2．郭改会，傅仁杰．170例中老年急性脑梗死证候特点分析．安徽中医学院学报，2002，21 (6)；58-60．
3．郭忠，韩明向，周宜轩，郭幸福．300例高黏综合征临床证候学调查与分析．中医药临床杂志，2006，18(4)；335-337．
4．高渝军，李荣亨，覃乔静．血FDP，D-二聚体与气虚血瘀证．四川省卫生管理干部学院学报，2001，20(4)；249-250．
5．吴大梅，冯麟，杨爱国，冯济凤．从五脏病机浅谈血癖证的形成．贵阳中医学院学报，2006，28(3)；6-7．
6．武留信，吕敏，师绿江，史平，康晟，宋蕾，任福秀，石英玲，刘广莉，武阳丰．1202例中老年人颈动脉硬度及相关因素研究．中华心血管病杂志，2004，32(8)；723-728．
7．朱文华，方力争，孟文芳，陈建华．急性心脑血管事件与代谢综合征的相关性研究．中华急诊医学杂志，2006，15(2)；168-170．
8. Wallace AM, Mc Mahon AD, Packard CJ, et al. Plasma leptin and her risk of cardiovaccular disease in the west of Scotland coronary prevention study [J]. Circulation, 2001, 104 (25); 39052-39056.
9．施小梅，俞茂华，吴晓琰，黄延焱．老年人群代谢综合征与脑血管病的相关分析．中国临床神经科学，2004，12(1)；66-68．
10．顾东风，黄广勇，吴锡桂，段秀芳．中国人群体重指数及其与心脑血管病的关系．中华医学杂志，2002，82(15)；1018-1021．
11. Jacob C. Seidell, W. M. Monique Verschuren, Edith M. Vanheer, et al. Over weight, under weight, and mortality. A Prospective Study of 48287 men and women. Arch Intern Med, 1996, 156; 958-936.
12．左秀美，邬英全．脑血管病死亡与体重指数及胆固醇相关性的研究．牡丹江医学院学报，2004，25(2)；1-3．
13．王坤玲，王魁亮，郭军．代谢综合征中医证型与胰岛素抵抗的关系．新疆中医药，2006，24(5)；25-28．
14．陈贵海，陈利国．肥胖与血瘀证形成的相关性研究．山东中医药大学学报，2002，26(2)；129-131．
15．周志焕．痰瘀并治法对单纯性肥胖大鼠治疗作用的实验研究．河北中医，2006，28(3)； 221-223．
16．吴启锋，熊尚全，温茂祥，杨永东，兰东辉．高血压病中医证型与盐敏感性及体重的关系．中国中西医结合杂志，2002，22(11)；865．
17．余学庆，李建生、庆慧．中风病证候影响因素的研究．新中医，2003，35(11)；20-22．
18．阎蔚，刘敏，徐光华．中医辨证分型治疗脂肪肝对患者体重指数、腰臀围比及血糖血脂水平影响的临床研究．新中医，2006，38(6)；42-43．
1．田金州，韩明向，涂晋文，杨承芝，杨惠民，邹忆怀，刘峘．《血管性痴呆的诊断、辨证及疗效评价标准》．北京中医大学学报，2001，23(5)；24-30．
2．孙宁玲．高血压与脑卒中[J]．新医学，2003，34(3)；137-139．
3．王显，程永杰，袁丽荣，等．高血压病左心室肥厚的阴阳属性及其治疗[J]．吉林中医药，1997，17(6)；4．
4．杨传华，韩玉水，刘政．中医药逆转高血压左心室肥厚的理论探讨[J]．河北中医，1994，16(5)；1-2．
5．周文强，刘德桓，林惠琴，等．脑卒中中医证型与临床总体评价的相关性研究[J]．广西中医学院学报，2002，5(3)；24-26．
6．姚魁武，王阶，朱翠玲，武继涛，王恰如，王在意．不同疾病血瘀证量化诊断的比较研究．辽宁中医杂志，2006，33(11)；1381-1383．
7．洪永敦，黄衍寿，吴辉，陈宇鹏，李斐媛，莫鸿辉．冠心病中医证候与炎症因子关系的临床研究．广州中医药大学学报，2005，22(2)；81-86．
8. Shah PK. Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol Clin, 1999, 17; 270-281.
9. Ross R. Atherosclerosis--an inflammatory disease [J].N Engl J Med, 1999, 340; 115-126.
10. Ridker PM, Hennekens CH, Burning JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J].N Engl J Med, 2000, 342(12): 836-842.
11. Ridker PM, RifaiN, Stampfer M J, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men[J].Circulation, 2000, 101(15); 1767-1772.
12. Caligiuri G, Mcoletti A, Poirier B, et al. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. Clin Invest, 2002, 109(6); 745-753.
13．姚魁武，杨戈，王阶．高血压病血瘀证患者血液学指标判别分析．世界科学技术-中 医药现代化基础研究(World Science and Technology／Modernization of Traditional Chinese Medicine and Materia Medica)，2006，8(5)；30-42．
14．丘瑞香，罗致强，朱雅宜，秦鉴．冠心病血瘀证血液理化特性与中医证型相关性研究．中医杂志，2002，43(5)；378-379．
15．丁邦晗，严夏，林晓忠，李松．血脂异常与胸痹心痛基本证型的相关性分析．辽宁中医杂志，2006，33(10)；1261-1262．
16．李松，丁邦晗，张敏州，蚁楷宏，邹旭，陈伯钧，林晓忠，刘泽银．365例胸痹心痛患者证型血脂分析．广州中医药大学学报，2005，22(2)；87-97．
17．顾衡强，陈美华，邹襄谷，吴松鹰，李永鉴，林求诚．老年高血压颈动脉硬化多因素中医证型分析．福建中医学院学报，2006，16(3)；7-10．
18．杨牧祥，于文涛，魏查，王长垠，王秉岳，安俊岐．缺血性中风患者证型分布规律的研究．中医药学刊，2006，24(9)；1593-1595．
19．张国平，刘华，别晓东．不同类型中风血瘀证患者血液流变学和凝血谱指标的研究．全科医学临床与教育，2006，4(3)；204-210．
20．张彦丽，邢秀吉，林求诚，田德禄．轻度脑动脉硬化症和脑梗塞血瘀证的相关性基础研究．中国中医基础医学杂志(Chinese J Basic Med TCM)，2001，7(6)；58-60．
21．邓常青，江劲波．脑梗塞患者凝血分子标记物变化与血瘀证的关系．中国中医基础医学杂志，1999，5(10)；58-60．
22．钟建，何立群，丁小强．146例慢性肾功能衰竭患者临床分型及相关生化指标研究．中医杂志，2006，47(5)；373-377．
23．陈志伟．慢性肾功能衰竭中医辨证分型与实验室检查的关系．中西医结合杂志，1998，8(7)；395．
1．田金洲，韩明向，涂晋文，杨承芝，杨惠民，邹忆怀，刘垣．《血管性痴呆的诊断、辨证及疗效评价标准》．北京中医大学学报，2001，23(5)；24-30．
2．易兴阳，袁光固，周东，等．脑梗死患者周围血细胞因子研究[J]．中风与神经疾病杂志，1996，13(6)；333-335．
3．易兴阳，潘继豹，池丽芬，陈存木，袁光固．进展性缺血性脑卒中患者细胞因子及黏附分子的研究．中国神经免疫学和神经病学杂志，2006，13(3)；169-172．
4．叶心国，李承晏，毛善平．急性脑梗死患者血清TNF-α、IL-1β和sICAM-1含量变化．中华急诊医学杂志，2003，12(1)；32-34．
5．王建茹，冯忠军，李娜，曹志坤．急性脑梗塞患者血IL-1、IL-6、TNF、TM水平的变化及临床意义．中国免疫学杂志，2004，20(6)；431-432．
6. Robert MF, Valeria G, Hideaki H, et al .Expression of a dominant negative of interleukirrlp converting enzyme in transgenic mice prevents neuronal cell death induced by tropic fator withdrawal and ischemic brain injury[J]. EXP Med, 1997, 185: 933-940.
7. Frank CB, Raymond F W, Patricia AS, et al. Ischemic preconditioning and brain tolerance[J]. Stroke, 1998, 29: 1937-1951.
8. Clearfield MB. C-reactive protein: a new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc, 2005, 105(9): 409-416.
9．骆杰伟，陈慧，吴小盈，兰健姿，邱志洁，严晓华，张雪梅．高血压病血瘀证患者高敏C反应蛋白的临床分析．中国中西医结合杂志，2006，26(7)；648-650．
10. Emsley HC, Smith CJ, Grain CM, et al. An early and substained per pheral inflammatory response in acute ischemic stroke:relationship with infection and atherosclerosis [J].J Neuroimmunol, 2003, 139(1-2): 93-101.
11．禹爱梅，邹玉安．急性脑梗死患者血清中IL-1β及IL-6水平变化的研究．河北北方学院学报，2006，23(2)；38-39．
12．曹姣妃，刘宁，梁德胜，裴世澄．急性脑血管病患者血清hs-CRP，TNF-α和IL-6的动态变化及临床意义．第四军医大学学报，2004，25(2)：173-175．
13．陈品 洪丽 邓建中．脑梗死患者血清TNF-α、IL-6含量的变化及意义．实用老年医学，2006，20(5)：57-59．
14. TezonoK, Sarker KP, Kikuchi H, et al. Bioactivity of the vascular endothelial growth factor trapped in fibrin clots: production of IL-6 and IL-8 in monocytes by fibrin clots [J]. Hae wpstasis, 2001, 31(2); 71-79.
15．杜凯音，董莉，孙喜山，李香玉．中风中医辨证分型与血清IL-6关系的研究．吉林中医药，2003，23(9)：5-6．
16．顾卫，谭峰，吴海科，王金良，黄涛．急性脑梗死辨证分型与细胞因子的关系．中国中西医结合急救杂志，2002，9(5)；302-304．
17．关少侠，谌剑飞，丁萍，等．急性缺血性中风始发状态风证与免疫细胞因子关系的研究[J]．深圳中西医结合杂志，2001，11(5)；266-268．
18．黄庆仪，谌剑飞，马雅玲，等．急性缺血性中风气虚证与TNF-a、IL-6的相关性探讨[J]．吉林中医药，2001，21(3)：4-5．
19．洪永敦，黄衍寿，吴辉，陈宇鹏，李斐媛，莫鸿辉．冠心病中医证候与炎症因子关系的临床研究．广州中医药大学学报，2005，22(2)；81-86．
20．姚魁武，王阶，朱翠玲，武继涛，王恰如，王在意．不同疾病血瘀证量化诊断的比较研究．辽宁中医杂志，2006，33(11)；1381-1383．
21. Intiso D, Zarrelli MM, Lagioia G, Di Rienzo F, Checchia De Ambrosio C, Simone P, Tonali P, Cioffi Dagger RP. Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol Sci, 2004 Feb, 24(6): 390-396.
22．毕国荣，卢丽萍，剑非．动态观察急性脑血管病患者血浆肿瘤坏死因子-α含量变化的临床意义．临床神经病学杂志，1999，12(2)；86-87．
23．黄作毅，韩凤，吴军．急性脑血管病患者血浆TNF，IL-6含量研究中风与神经疾病杂志，1999，16(2)：103-104．
24. Krupinski J, Kumar P, Kumar S, et al. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans[J]. Stroke, 1996, 27(5); 852-857.
25．程利萍，贾建民，濮孟久．IL-1β、TNF-α、TGF-β1与缺血性脑损害相关性研究．中国神经免疫学和神经病学杂志，2004，11(1)；36-38．
26．何志义，欧阳巅，张强，范红杰，房晓，吕昌龙．老年急性脑血管病患者细胞因子及其受体的研究．中华老年心脑血管病杂志，2001，3(5)；322-325．
27．王钢，黄建群．脑卒中患者转化生长因子与细胞粘附因子检测及分析[J]．中华内科杂志，2000，39(5)；309-311．
28．郭正良，傅毅，辛晓瑜，曾丽莉，沈介明，刘建荣，陈生弟．急性脑梗死患者ox-LDL、TGF-β1和VCAM-1的检测．上海交通大学学报(医学版)，2006，26(11)：1274-1276．
29. Lehxm ann E, et al. Microglia and macrophages axe major sources of locally proced transforming growth factor-betal after transient middle cerebral artery occlusion in rats. Glia, 1998, 24(4): 437-438.
30. Kawamata T, Ren J, Chan TC. Intracisternal osteogenic Protein-1 enhances functional recovery folowing foca stoke. Neuroreport, 1998, 9(7); 1441-1445.
31. Mallat Z, Gojova A, Marahiol-Fournigault C, et al. Inhibition of transforming growth factor-beta signaling accelerates atherosalerosis and induces an unstable plaque phenotype in mice[J].Circ Res, 2001, 89(10): 930-934.
32. Argmann(:A, Van Den Diepstraten CH, Sawyez CG, et al. Transforming growth factor-β1 inhibits macrophage aholesteryl ester accumulation induced by native and ox-idized VLDL remnants[J]. Arterioscler Throm Vasc Biol, 2001, 21(12): 2011-2018.
33. Saiura A, Sara M, Hirata Y, et al. Zranilast inhibits transplant-associated coronary arteriosclerosis in a murine model of cardiac;transplantation[J]. Eur J Pharmacol, 2001, 433(2-3): 163-168.
34. Chen X, Ren S, Ma MG, et al. Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-beta in carotid artery of atherosolerotic rabbits[J]. Atherosolerosis, 2003, 169(1): 31-40.
35．金惠铭，卢健，殷莲华．细胞分子病理生理学[M]．郑州大学出版社，2002，110-125．
36. Castellanos M, Castillo J, Garcia MM, et al.Inflammation mediated damage in progressing lacunar infarctions[J].Stroke, 2002, 33: 982-987.
37．袁肇凯，黄献平，谭光波，毛以林，卢芳国，胡志希，田松，李杰，孙贵香．冠心病血瘀证血管内皮细胞功能的检测分析．中国中西医结合杂志，2006，26(5)；407-410．
38．胡小勤，陈利国．血管内皮细胞粘附分子与血瘀证相关性探讨．陕西中医，2005，26(3)；249-250．
39. Wu Y, Zhu B D. Effect of Danggui Buxue Decoction on proliferation and expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells [J]. J West China Univ Med Sci (华西医科大学学报), 2001, 32 (4): 593-595.
40. Zhang Y J, Zhao L G, Wu X Z. Effect of Huoxuehuayu Decoction on expression of adhesive molecular of intrapulmonic endothelial cell of rats suffered from SAP [J]. Chin Tradit Herb Drugs(中草药), 2001, 32(11): 1010-1011.
41. Hao Y, Qiu Q Y, W J. Effect of astragalus polysaccharin(APS) on ymphocyte-endothelium adhesion and the molecular mechanism [J]. Immunnol J(免疫学杂志), 2000, 16(3): 206-209.
42．陈利国，屈援，葛红颖，胡小勤，聂优爱，何孟栖．补阳还五汤对血瘀证大鼠血管内皮细胞粘附分子表达的影响．Chinese Traditional and Herbal Drugs(中草药)，2005，36(5)；706-709．
43．李松，丁邦晗，张敏州，蚁楷宏，邹旭，陈伯钧，林晓忠，刘泽银．365例胸痹心痛患者证型与血脂分析．广州中医药大学学报，2005，22(2)；87-97．
44．邓丽娅，张印新．活血化瘀对血管内皮功能的影响．山东中医杂志，2006，25(11)；732-724
45. Tenglia AN, Buda AT, Wilkins RG, et al. Levels of expression of P-selection, E-selection and intercellular adhesion molecule-1 in coronary atherectomy specimens from patients with stable and unstable angia [J]. Am J Cardiol, 1997, 79(6); 742-747.
46. Ogawa H,Yasue H,Miyao Y, et al. Plasma soluble intercellular adhesion molecule-1 levels in coronary circulation in patients with unstable angina[J]. Am J Cardiol, 1999, 83(1); 38-42.
1. Jarskog LF, Gilmore JH. Developmental expression of Bcl-2 protein in human cortex. Brain Res Dev Brain Res, 2000, 119(2); 225-230.
2．廖维靖，Frank Wieg，Ulrich Dirnagl．脑缺血损伤的病理生理机制—损伤级联反应．国外医学脑血管疾病分册，1998，6(4)；197-202．
3. Olney J W. Brain lesion, obesity and other disturbances in mice treated with monosodium glutamate. Science, 1969, 164; 719-721.
4. Beal MF. Mechanisms of excitotoxicity in neuxologic diseases. FASEB J, 1992, 6(15); 3338-3344.
5. Greenamyre JT, Greene JG, Higgins DS, et al.Mechanism of selective neuronal vulnerability:Bioenergetics and excitotoxicity. In:Marwak J, Prasad KN, Teitelbaum H, eds. Neural Transplantation, CNS Neuronal Injury, and Regeneration. New York:CRC Press, 1994, 71-80.
6. Choi DW. Excitotoxic cell death. J Neurobiol, 1992, 23:1261-1276
7. Olney JW, Wozniak DF, Farber NB. Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies Arch Neurol, 1997, 54; 1234-1240.
8. Rice AC, Delorenzo RJ. NMDA receptor activation during status epilepticus is required for the development for epilepsy: Brain Res, 1998, 7820 (2); 240-247.
9. Castillo J, Davalos A, Noya M. Progression of ischemic stroke and excitotoxicity amino acids. Lancet, 1997, 349; 79-83.
10．贾建平．缺血性脑卒中病理生理．2003神经病学新进展[M]．第一版．北京：人民卫生出版社，2003，55-56．
11. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Eng J Med, 1994, 330; 613-622.
12. Tonumoto H, Takemoto O, Akiguchi I, et al. Immunoelectron microscopic study of c-Fos, c—Jun and beat shock protein after transient cerebral ischemia in gerbils I. J Acts. Neuropathol(Berl), 1999, 97(1); 22.
13 . Koistinaho 3, Hokfelt T. Altered gene expression in brain ischemic Neuroreport, 1997, 8(2); 1.
14. Astrup J, Symon L, Branston NM, et al. Cortical evoked potential and extracellular K+ and H+ at critical levels of brains ischemia. Stroke, 1977, 8; 51.
15. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol, 1994, 36(4); 557-565.
16. Hakim Am. Ischemic penumbra: the therapeutic window. Neurology, 1998, 51(suppl3): 844-846.
17. Grinvald A, Shoham D, Shmuel A, et al. In viva optical imaging of cortical architecture and dyna mics . I n:Windhorst U, Johansson H, ed. Modern Techniques in Neuroscience Research. Berlin:Springer, 1999, 893-969.
18. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol, 1999, 17(9); 2941-2953. Review.
19. Stennicke HR, Salvesen GS . Caspases - controlling intracellular signals by protease zymogen activation. Biochim Biophys Acta, 2000 Mar 7, 1477(1-2); 299-306. Review.
20. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 1994 Jun, 9(6); 1799-1805.
21. Petito CK, Torres-Munoz J, Roberts B, et al. DNA fragmentation follows delayed neuronal death in CA1 neurons exposed to transient global ischemia in the rat. J Cereb Blood Flow Metab, 1997 Sep, 17(9); 967-976.
22. Lindner V, Collins T. Expression of NF-κB and 1κB-aby aortic endothelaium in a arterial injury model[J] . Am J Pathol, 1996, 148; 472.
23. Pueyo ME, Gonzalez W, Mcoletti A, et al. Angiotensin 11 stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor kappa B activation induced by intracellular oxidative stress [J]. Arterioscler Thromb Vasc Biol, 2000, 20; 645-651.
24. Sandner P, Wolf K, Bergmaier U, et al . Hypoxia and cobalt stimulate vascular endothelial growth factor receptor gene expression in rats . Pflugers Arch, 1997, 433; 803-808.
25. Jiang BH, Rue E, Wang GL, et al. Dimerization, DNA binding, and transactivation properties of hy-poxia-inducible factor-1 . J Biol Chem, 1996, 271 ; 17771-17778.
26. Semenza GL, Agani F, Booth G, et al. Structural and functional analysis of hypoxia-inducible factor-1. Kid Int, 1997, 51; 553-555.
27. Liu PK, Grossman RG, Hsu CY, et al.Ischemic injury and faulty gene transcripts in the brain[J].Trends Neurosci, 2001, 24(10); 581-588.
28. Hue RI, Padmaja S.The reaction of NO with superoxide[J]. Free Radio Res Commun, 1998, 18(4); 195-199.
29. Sharp FR, Lu A, Tang Y, et al. Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab, 2000 Jul, 20(7); 1011-1032. Review.
30. Ruscher K, Isaev N, Trendelenburg G, et al. Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons. Neurosci Lett, 1998 Sep 25, 254(2); 117-120.
31. Stanimirovic DB, Wong J, Shapiro A, et al.Increase in surface expression of ICAM-1 and E-selectin in human cerebromicrovascular endothelial cells subjected to ischemia-like insults[J].Neurochi suppl wien, 1997, 70; 12-16.
32. Webster SD, Park M, Fonseca MI, et al, Structural and functional evidence for microglial expression of CloR(P), the Clq receptor that enhances phagocvtosis[J]. J Leukoc Biol, 2000, 67(1): 109-116.
33. Dawson VL, Dawson TM. Nitric oxide in neurodegeneration. Prog Brain Res, 1998, 118; 215-229.
34. Dong Y, Benveniste EN. Immune function of astrocytes. Glia, 2001, 36; 180-190.
35．张剑，田野苹．CNS中抗原递呈细胞调节T细胞对CNS抗原的应答．中国神经科学杂志，2002August，18(3)；639-642．
36. Touzani O, Boutin H, Chuquet J, et al. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroi m munol, 1999, 100; 203-215.
37. Zheng GZ, Michael C, Anton G. Cerebral vessels express interleukin-1β after focal cerebral ischemia[J].Brain Research, 1998, 784; 210-217.
38．狄政莉，万琪，来华安，王洪典．IL-1β和IL-6在脑缺血再灌注微血管内皮细胞炎症反应中的作用．西安医科大学学报，2001，22(5)；432-434．
39. Ding Y, Young CN, Li J, et al. Reduced inflammatory mediator expression by pre-reperfusion infusion into ischemic territory in rats: a real-time polymerase chain reaction analysis. Neuroscience Letters, 2003 Dec 26, 353(3); 173-176.
40．杜柏岩，关秀茹，高光强，等．IL-β对大鼠脑缺血再灌注损伤的意义．哈尔滨医科大学学报，2000，34(2)；124-125．
41．田金洲主编．《血管性痴呆》．人民卫生出版社，2003，259．
42. Thomas JD. The role of inflammation after acute stroke[J].Neurolgy, 1998, 51; s62-68.
43. Legos JJ, Whitmore RG, Erhardt JA, et al.Quantitative changes in interleukin in proteins following focal stroke in the ratf [J]. Neurosci lett, 2000, 282(3); 189-925.
44. Block F,Peters M, Nolden- Koch M.Expression of IL-6 in the ischemic penumbra[J].Neuroreport, 2000, 11(5); 963-967.
45. Loddick SA, Turnbull AV, Rothwell NJ.Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat[J].lereb Blood Flow Metab, 1998, 18; 176-179.
46. Barone FC, Arvin B, White RE, et al. Tumor necrosis factor alpha:A mediator of focal ischemic brain injury. Stroke, 1997, 28; 1233-1244.
47. Jean WC, Spellman SR, Nussbaum ES, et al. Reperfusion injury after focal cerebral ischemia:the role of inflammation and the therapeutic horizon. Neurosurgery, 1998, 43; 1382-1397.
48. Buttini M, Appel K, Sauter A, et al. Expression of tumor necrosis factor alpha after focal cerebral ischemia in the rat[J]. Neuroscience, 1996, 71; 1-16.
49．张莉莉，王景周，周华东，陈曼娥．肿瘤坏死因子-α在大鼠脑缺血再灌注损伤中的作用机制．中华老年医学杂志，2003年，22(2)；102-104．
50．胡建鹏，王键，郜峦，等．局灶性脑缺血再灌注时神经元、胶质细胞形态变化与TNF-α表达相关的实验研究．中国病理生理杂志，2004，20(7)：1251-1255．
51．张玲，余绍祖，吴国祥．大鼠脑缺血再灌注后TNF-α，IL-β及细胞间粘附分子-1mRNA的表达．卒中与神经疾病，2001，8(2)；77-79．
52. Lehxm ann E, et al. M icroglia and macrophages are major sources of locally proced transforming growth factor-betal after transient middle cerebral artery occlusion in rats. Glia, 1998, 24(4); 437-438.
53．刘士民，郭玉璞．大鼠局灶脑缺血／再灌注模型TGTβ的表达．基础医学与临床，2000，20(1)；70-73．
54．王社军，蒋传路，康军，胡韶山，李永力，葛云龙，杨立庄，戴有利．大鼠脑缺血／再灌注后血脑屏障通透性的改变及转移生长因子β1的表达．中华神经外科杂志，2003，19(1)；51-54．
55. Wang XK, Yue T, White TF, et al. Transforming growth factor beta-i exhibits delayed gene expression following focal cerebral ischem ia. Brain Res Bull, 1995, 36(6); 607-609.
56. Clark WM, Lauten JD, Lessov N, et al. Time course of ICAM-1 expression and leukocyte subset infiltration in rat forehrain ischemia. Mol Chem neurophathol, 1995, 26; 213.
57. Kacimi R, Karliner JS, Koudssi F, et al. Expression and regulation of adhesion molecules in Cardiac cells by cytokines response to acute hypoxia[J].Circ Res, 1998, 82(5); 576-586.
58. Dixon GL, Heyderman RS, van der Ley P, et al.High-level endothelial F selectin(CD62E) cell adhesion molecule expression by a lipopolysaccharide-deficient strain of Neisseria meningitidis despite poor activation of NF-kappaB transcription factor[J].Clin Exp Immunol, 2004, 135(1); 85-93.
59. Argenbright L W, Barton R W. Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo.The Shwartzman reaction revisited[J] Clin Invest, 1992, 89(1); 259-272.
60．崔尧元，余勇，张晓彪，刘银坤．细胞间粘附分子1、肿瘤坏死因子α转录水平在缺血再灌注大鼠脑皮质中表达的相关性．中华实验外科杂志，1999，16(5)；442-443．
61．葛海良，Wen Ye，Guo-Yuan Yang，A．Lorris Betz．小鼠局灶性脑缺血模型中细胞间粘附分子-1表达升高．中国神经免疫学和神经病学杂志，1999，6(3)；147-152．
62. Zhang RL, Chopp M, Zaloga C, et al. The temporal profiles of ICAM-1 protein and Mrna expression after transient MCA occlusion in the rat. Brain Res, 1995, 682; 182.
63. Yang GY, Gong C, Qin Z, et al. Inhibition of TNF-α attenuate infarct volume and ICAM-1 expression in ischemic mouse brain. Neuro Report, 1998, 9; 2131.
64. Yang GY, Mao Y, Zhou LF, et al. Attenuation of temporary focal cerebral ischemic injury in the mouse following transfection with IL-1 receptor antagonist. Brain Res Mol Brain Res, 1999, 72; 129.
65. De Graba TJ. The role of inflammation after acute stroke:utility of put suinganti-adhesion molecule therany. Neuroloey, 1998, 51; S62.
66. Yang GY, Schielke GP, Gong C, et al. Expression of TNF-α and ICAM-1 after focal cerebral ischemia in IL-1β converting enzyme deficient mice. J Cereb Blood Flow Metab, 1999, 19; 1109.
67. Schroeter M, Eury P, Jander S. Inflammatory gene expression in focal cortical brain ischemia: differences between rats and mice. Brain Res Mol Brain Res, 2003 Sep 10, 117(1); 1-7.
68．钟照华，李国忠，李呼伦，等．人缺血脑组织中TNF-α和IL-1β的表达．细胞与分子免疫学杂志(Chin J Cell Mol Immunol)，2003，19(4)；349-363．
69. Tarkowski E, Rosengren L, Blomstrand C, et al. Early intrathecal production of interleukin-6 predicts the volume of brain lesion in stroke[J].Stroke, 1995, 26; 1393-1398.
70．易兴阳，袁光固，周东，等．脑梗死患者周围血细胞因子研究[J]．中风与神经疾病杂志，1996，13(6)；333-335．
71．易兴阳，潘继豹，池丽芬，陈存木，袁光固．进展性缺血性脑卒中患者细胞因子及黏附分子的研究．中国神经免疫学和神经病学杂志，2006，13(3)；169-172．
72．禹爱梅，邹玉安．急性脑梗死患者血清中IL-1β及IL-6水平变化的研究．河北北方学院学报，2006，23(2)；38-39．
73．叶心国，李承晏，毛善平．急性脑梗死患者血清TNF-α、IL-1β和sICAM-1含量变化．中华急诊医学杂志，2003，12(1)；32-34．
74．王建茹，冯忠军，李娜，曹志坤．急性脑梗塞患者血ILI、IL6、TNF、TM水平的变化及临床意义．中国免疫学杂志，2004，20(6)；431-432．
75. Robert MF, Valeria G, Hideaki H, et al.Expression of a dominant negative of interleukirrlp converting enzyme in transgenic mice prevents neuronal cell death induced by tropic fator withdrawal and ischemic brain injury[J]. EXP Med, 1997, 185; 933-940.
76. Frank CB, Raymond F W, Patricia AS, et al. Ischemic preconditioning and brain tolerance[J].Stroke, 1998, 29; 1937-1951.
77. Emsley HC, Smith CJ, Grain CM, et al. An early and substained per pheral inflammatory response in acute ischemic stroke:relationship with infection and atherosclerosis [J].J Neuroimmunol, 2003, 139(1-2); 93-101.
78．曹姣妃，刘宁，梁德胜，裴世澄．急性脑血管病患者血清hs-CRP，TNF-α和IL-6的动态变化及临床意义．第四军医大学学报，2004，25(2)；173-175．
79. TezonoK, Sarker KP, Kikuchi H, et al Bioactivity of the vascular endothelial growth factor trapped in fibrin clots: production of Ih-6 and IL-8 in monocytes by fibrin clots [J]. Hae wpstasis, 2001, 31(2); 71-79.
80．陈品 洪丽 邓建中．脑梗死患者血清TNF-α、IL-6含量的变化及意义．实用老年医学，2006，20(5)；57-59．
81. Intiso D, Zarrelli MM, Lagioia G, Di Rienzo F, Checchia De Ambrosio C, Simone P, Tonali P, Cioffi Dagger RP. Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol Sci, 2004 Feb, 24(6): 390-396.
82．毕国荣，卢丽萍，剑非．动态观察急性脑血管病患者血浆肿瘤坏死因子-α含量变化的临床意义．临床神经病学杂志，1999，12(2)；86-87．
83．黄作毅，韩凤，吴军．急性脑血管病患者血浆TNF-α，IL-6含量研究中风与神经疾病杂志，1999，16(2)；103-104．
84. Krupinski J, Kumar P, Kumar S, et al. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans[J]. Stroke, 1996,27(5);852-857.
85．王钢，黄建群．脑卒中患者转化生长因子与细胞粘附因子检测及分析[J]．中华内科杂志，2000，39(5)：309-311．
86．顾天华，龚艳春，王德治，郭冀珍．高血压合并腔隙性脑梗死转移生长因子β1的变化．上海第二医科大学学报，2002，22(6)；515-517．
87．程利萍，贾建民，濮孟久．IL-1β、TNF-α、TGF-β1与缺血性脑损害相关性研究．中国神经免疫学和神经病学杂志，2004，11(1)；36-38．
88．何志义，欧阳巅，张强，范红杰，房晓，吕昌龙．老年急性脑血管病患者细胞因子及其受体的研究．中华老年心脑血管病杂志，2001，3(5)；322-325．
89．郭正良，傅毅，辛晓瑜，曾丽莉，沈介明，刘建荣，陈生弟．急性脑梗死患者ox-LDL、TGF-β1和VCAM-1的检测．上海交通大学学报(医学版)，2006，26(11)：1274-1276．
90. Kawamata T, Ren J, Chan TC. Intracisternal osteogenic Protein-1 enhances functional recovery folowing foca stoke. Neuroreport, 1998, 9(7): 1441-1445.
91. Castellanos M, Castillo J, Carcia MM, et al. Inflammation mediated damage in progressing lacunar infarc-tions[J]. Stroke, 2002, 33: 982-987.
1．翁为良主编．《活血化瘀治疗疑难病》．学苑出版社，2003年，第2版．
2．国家技术监督局．中华人民共和国国家标准．中医病证分类与代码．中医证候名称与分类代码，北京：中国标准出版社，1995，1．
3．国家技术监督局．中华人民共和国国家标准．中医临床诊疗术语证候部分．北京：中国标准出版社，1997，1．
4．国家中医药管理局．中华人民共和国中医药行业标准．中医病证诊断疗效标准，南京：南京大学出版社，1994，1．
5．中国中西医结合研究会老年病专业委员会．中医虚症辨证参考标准．中西医结合杂志，1986，6(10)：598．
6．中西医结合心血管学会．冠心病中医辨证标准．中西医结合杂志，1991，11(3)；257．
7．1980年全国冠心病辨证论治研究座谈会．冠心病(心绞痛，心肌梗塞)中医辨证试行标准．中医杂志，1980，21(8)；46．
8．中华全国中医学会内科学会．中风病中医诊断、疗效评定标准．中国医药学报，1986，1(2)：56-57．
9．中西医结合学会心血管学会．冠心病中医辨证标准．中西医结合杂志，1991，11(5)：129．
10．中国中医药学会消渴病专业委员会．消渴病(糖尿病)中医分期辨证与疗效评定标准．中国医药学报，1993，8(3)：54．
11．田金州，韩明向，涂晋文等，血管性痴呆诊断、辨证及疗效评定标准(研究用)．中国老年学杂志，2002，5；56-60．
12．国家中医药管理局脑病急症科研组．中风病辨证诊断标准(试行)．北京中医药大学学报，1994，17(11)；64-65．
13．国家中医药管理局脑病急症科研组．中风病诊断与疗效评定标准的临床验证报告．北京中医药大学学报，1996，19(1)；57-59．
14．中国中西医结合研究第一次全国活血化瘀学术会议．血瘀证诊断试行标准[S]．西医结合杂志，1983，3(3)；封二．
15．第二届全国活血化瘀研究学术会议修订血瘀证诊断标准．1986年11月，广州．
16．李先涛，赖世隆，梁为雄．运用循证医学对血瘀证诊断标准研究文献的评价．广州中医药大学学报，2003，20(2)；168-170．
17．吴承玉．血瘀证的研究发展脉络与评述．南京中医药大学学报，2004，20(3)；133-136．
18．王阶，陈可冀，翁维良，钱振淮，王怡，刘剑刚，葛争艳．血瘀证诊断标准的研究．中西医结合杂志，1988，8(10)；585-589．
19．王阶，姚魁武．血瘀证诊断标准研究述要及思考．中国中医药信息杂志，2004，11(1)；17-19．
20．中西医结合学会活血化瘀专业研究会．血瘀证诊断标准[S]．中西医结合杂志，1987，7(3)：129．
21．姚魁武，王阶，朱翠玲，武继涛，王恰如，王在意．不同疾病血瘀证量化诊断的比较研究．辽宁中医杂志，2006，33(11)；1381-1383．
22．朱文锋，吴润球，瞿岳云．中医诊断的特色和优势．湖南中医学院学报，2000，(20)3：40-42．
23．中国中医药学会内科学会消渴病专业委员会1992．消渴病(糖尿病)中医分期辨证与疗效评定标准．中国医药学报，1993，8(3)；54-56．
24．国家中医药管理局脑病急症科研组．中风病辨证诊断标准(试行)．北京中医药大学学报，1991，17(3)；64-66．
25．1996年度国家中医药管理局中医药基础研究奖奖励项目．中国中医药科技，1997，4(5)：299．
27．中风病证候学与临床诊断的研究科研协作组．《中风病证候诊断标准》的临床验证研究．北京中医药大学学报，1994，17(6)；41-43．
28．章桂康．中风病中医诊断疗效评定标准．中医杂志，1992，4；39．
29．陈文为．中药新药临床研究指导原则．第1辑．第1版．北京：人民卫生出版社，1993，116-118．
30．彭世洪．急性脑梗塞的中医分型与CT影像的关系．衡阳医学院学报，1999，27(1)：50-51．
31．王顺道，任占利，杜梦华，解庆凡，贾滋欣，王永炎．中风病始发态证候与脑病理改变相关关系的研究．中国中医急症，1999，8(1)；36-39．
32．王玉来，郑慧，刘文娜．中风急症证候分析．中国中医急症，1995，4(2)；74-79．
33．梁伟雄，温泽淮，赖世隆，莫传伟，黄培新，刘茂才，王奇．中风病中医证候特征与脑病理改变的相关关系研究．新中医，1999，31(7)；41-42．
34．梁伟雄，赖世雄，刘茂才，莫传伟，黄培新，温泽淮，王奇，陈云波．中风病中医证候与相关因素分析．广州中医药大学学报，1999，16(2)；81-84．
35．郭改会，傅仁杰．170例中老年急性脑梗死证候特点分析．安徽中医学院学报，2002，21(6)：35-37．
36．余学庆，李建生，庆慧．中风病证候影响因素的研究．新中医，2003，35(11)；20-22．
37．王顺道，司志国，黄宜兴，等．中风病证候的初步研究．中国中医急症，1995，4(2)；85-88．
38．王新志，韩群英，陈贺华主编．中华实用中风病大全．第1版．北京：人民卫生出版社，1996，1044-1048．
39．谌剑飞，关少侠，丁萍，李创鹏，梁浩荣，马雅玲，奚玉风，杨慧珊，蔡绍华，张艳玲，徐进华．中风急症证候研究与问题探讨．中国中西医结合急救杂志，2001，8(3)；169-171．
40．杨牧祥，于文涛，魏萱，王长垠，王秉岳，安俊岐．缺血性中风患者证型分布规律的研究．中医药学刊，2006，24(9)；1593-1595．
41．谌剑飞，关少侠，李创鹏，张萍．糖尿病缺血性中风证候特征与神经内分泌免疫网络、脑病理改变的关系研究．放射免疫学杂志，2000，13(3)；143-145．
42．刘健，戴慧寒，梁耀基，邱文克．广东顺德地区急性脑梗死患者中医证候与牛津郡社区卒中项目分型的相关性．中国临床康复，2005，9(21)；152-154．
43．周慎，易振佳，刘伍立，赵艳玲，岳增辉，王淑云，赵瑞成，蒋荣鑫，杨玉龄．757例中风后遗症中医证候与中风主症的相关性分析．湖南中医药导报，2003，9(8)；11-13．
44．王建华，王永炎．出血性中风、缺血性中风急性期证候演变规律的研究．中国中医急症，2001，10(4)；215-217．
45．杨利，黄燕，蔡业峰，杜宝新，陈红霞，卢明，黄培新．1418例中风患者痰瘀证候分布和演变规律探析．辽宁中医杂志，2004，31(6)；459-460．
46．郑筱萸主编．中药新药临床研究指导原则[S]．北京：中国医药科技出版社，2002，99-104．
47．陈贵廷，薛赛琴．最新国内外疾病诊疗标准[M]．北京学苑出版社，1992，650-654．
48．王永炎．完善中医辨证方法体系的建议．中医杂志，2004，45(10)；729-731．
49．赵连根．研究活血化成必须研究组织氧供[J]．中国中西医结合杂志，1992，12(12)；747．
50．俞征宙，方素钦，余启胜．中风病中医辨证分型与免疫功能变化的关系[J]．福建中医药，2000，31(3)：3-5．
51．杜凯音，董莉，孙喜山，李香玉．中风中医辨证分型与血清IL-6关系的研究．吉林中医药，2003，23(9)；5-6．
52．顾卫，谭峰，吴海科，王金良，黄涛．急性脑梗死辨证分型与细胞因子的关系．中国中西医结合急救杂志，2002，9(5)；302-304．
53．关少侠，谌剑飞，丁萍，等．急性缺血性中风始发状态风证与免疫细胞因子关系的研究[J]．深圳中西医结合杂志．2001：11(5)：266-268．
54．黄庆仪，谌剑飞，马雅玲，等．急性缺血性中风气虚证与TNF-a、IL-6的相关性探讨[J]．吉林中医药，2001，21(3)；4-5．
55．王艳芬，毕丽丽．腔隙性脑梗死中医辨证分型规律的探讨[J]．中医药信息，2001，18(3)；5．
56．张明，丁向东，魏国，等．中风病人不同证型全血SOD和血浆TXB2的相关性研究[J]．山东中医药大学学报，1998，22(5)；349-352．
57．顾卫，杨东，吴海科，等．脑血栓血瘀证患者血浆组织型纤溶酶原激活剂、纤溶酶原激活剂抑制物和α-颗粒膜蛋白含量变化的研究．中西医结合实用临床急救，1998，5(2)：52．
58．林松波，连棋周，庞明．急性脑梗塞中医辨证分型血管内皮细胞活行因子检测证的指标探讨．中国中西医结合杂志，2000，20(12)；911．
59．胡庆全．脑梗塞中医证型与微循环关系研究．中国微循环，2001，5(4)；306-307．
60．覃乔静，李荣亨．气虚血瘀证血浆NPY、ET、CGRP的改变及相关性研究．重庆医科大学学报，2003，28(2)；202-204．
61．姜春华．活血化瘀研究．上海：上海科技出版社，1981，41-113．
62．周活，田维君．100例气虚血瘀证血液流变学研究．武警医学，1990，7(6)；349．
63．吴汉卿，黄召谊，杨芙蓉．老年气虚血瘀证患者微循环和血液流变学特征及通心络胶囊的治疗作用．微循环学杂志，2004，14(2)；13-15．
64．张国平，刘华，别晓东．不同类型中风血瘀证患者血液流变学和凝血谱指标的研究．全科医学临床与教育，2006，4(3)；204-210．
65．孔令钧，李光华，李鲁扬．老年血瘀证与细胞黏附分子关系的探讨．山东中医药大学学报，2003，27(4)；274-276．
66．邓常青，江劲波．脑梗塞患者凝血分子标记物变化与血瘀证的关系．中国中医基础医学杂志，1999，5(10)；121．
67．林松波，陈健，梁晖，等．中风恢复期中医辨证分型与氧自由基脂质过氧代谢及微量元素的关系[J]．中医药学报，2000，2；53-55
68．马卫琴，陈皆乐，李小春，等．中风病中医辨证分型与抗氧化酶关系探讨[J]．中国中 医基础医学杂志，1999，5(10)；39-40．
69. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med, 1999, 340; 115-120.
70．时晶，田金洲，王永炎，朱爱华，尹军祥，武月萍，徐意．血瘀证的生物学基础研究．中华中医药杂志，2006，21(6)；363-364．